Streptococcal septicaemia

AB1_STREPTO_SEPSIS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — A40 Hospital discharge: ICD-9 — 038[0] Hospital discharge: ICD-8 — 038[0] Cause of death: ICD-10 — A40 Cause of death: ICD-9 — 038[0] Cause of death: ICD-8 — 038[0] 2 out of 7 registries used, show all original rules.	3363
4. Check minimum number of events None	3363
5. Include endpoints None	3363
6. Filter based on genotype QC (FinnGen only)	3363

Control definitions (FinnGen only)

Control exclude: AB1_OTHER_BACTERIAL

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF5

NAME	AB1_STREPTO_SEPSIS
CONTROL_EXCLUDE	AB1_OTHER_BACTERIAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	A40
HD_ICD_9	038[0]
HD_ICD_8	038[0]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	A40
COD_ICD_9	038[0]
COD_ICD_8	038[0]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Streptococcal septicaemia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	30449	13253	16974
Only index persons	24844	10973	13871
Unadjusted period prevalence (%)
Whole population	0.43	0.38	0.47
Only index persons	0.47	0.40	0.53
Median age at first event (years)
Whole population	60.80	62.34	59.49
Only index persons	60.39	61.75	59.32

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3363	1358	2005
Unadjusted period prevalence (%)	0.71	0.46	0.88
Median age at first event (years)	64.72	60.97	67.26

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2978: Matched controls
29779

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A40.9

ICD-10 Finland

Streptococcal sepsis, unspecified

3821.2

323.0

350

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

104.0

323.0

397

A49.9

ICD-10 Finland

Bacterial infection, unspecified

118.3

323.0

855

101

A40.8

ICD-10 Finland

Other streptococcal sepsis

+∞

323.0

1069

A46

ICD-10 Finland

Erysipelas

22.0

323.0

1005

673

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

+∞

323.0

929

J18.9

ICD-10 Finland

Pneumonia, unspecified

5.5

323.0

1432

4294

A41.9

ICD-10 Finland

Sepsis, unspecified

661.0

323.0

544

A40.0

ICD-10 Finland

Sepsis due to streptococcus, group A

+∞

323.0

383

R50.9

ICD-10 Finland

Fever, unspecified

6.4

283.7

861

1782

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.5

280.8

987

2444

A40.1

ICD-10 Finland

Sepsis due to streptococcus, group B

+∞

279.6

264

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.9

259.8

1825

8664

A41.8

ICD-10 Finland

Other specified sepsis

1338.5

255.9

246

C03CA01

ATC

furosemide; systemic

3.9

238.1

1386

5474

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

550.3

209.6

206

J01MA12

ATC

levofloxacin; systemic

4.0

182.3

885

2844

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

628.4

181.6

178

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.2

179.6

814

2452

TPH04

NOMESCO Finland

Cathetrisation of vein

3.7

175.2

945

3304

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

7.2

161.6

422

668

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

6.0

154.0

463

883

J01FF01

ATC

clindamycin; systemic

3.2

153.3

1057

4378

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

4.9

147.2

538

1282

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

4.1

141.4

628

1809

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

71.2

141.4

162

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.8

129.2

474

1123

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

10.2

128.1

265

283

S97

ICPC

Chronic ulcer skin

6.8

126.0

340

555

I50.9

ICD-10 Finland

Heart failure, unspecified

3.5

124.1

678

2301

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

7.1

120.8

315

489

J01CE08

ATC

benzathine benzylpenicillin; parenteral

160.2

117.2

123

JN4BD

NOMESCO Finland

Extensive body CT

4.0

115.3

520

1494

B01AA03

ATC

warfarin; systemic

2.8

113.9

908

3983

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

4.2

112.9

476

1284

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

3.1

112.5

767

3036

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.8

108.0

885

3928

B01AB05

ATC

enoxaparin; parenteral

2.5

103.6

1058

5310

WX892

NOMESCO Finland

Monitored bed care

4.5

101.7

396

983

N02AA05

ATC

oxycodone; systemic

3.3

101.6

606

2163

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

9.5

101.3

216

242

TPH07

NOMESCO Finland

Cathetrisation of artery

3.7

101.2

497

1524

TK800

NOMESCO Finland

Hemodialysis

12.9

99.2

181

149

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.5

98.9

521

1689

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.3

97.8

574

2018

SPAT1255

SPAT

Intravenous administration of medicine

4.9

97.2

344

772

N17.9

ICD-10 Finland

Acute renal failure, unspecified

7.2

96.9

247

368

J01DB01

ATC

cefalexin; oral

2.6

95.8

2423

18776

J01MA14

ATC

moxifloxacin; systemic

4.0

94.3

413

1142

WW500

NOMESCO Finland

Blood transfusion

6.9

90.9

239

372

I50.0

ICD-10 Finland

Congestive heart failure

4.1

89.7

389

1063

WX872

NOMESCO Finland

Intensive care

4.9

88.0

307

676

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

18.8

87.9

137

ZX120

NOMESCO Finland

Intravenous

3.8

84.7

403

1192

R4110

NOMESCO Finland

Physiotherapy

2.4

84.6

919

4658

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

4.5

84.3

323

783

WX408

NOMESCO Finland

General anesthesy, balanced

2.4

83.4

936

4813

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.4

82.6

920

4709

M04AA01

ATC

allopurinol; systemic

2.9

81.9

561

2172

C03DA01

ATC

spironolactone; oral

3.2

80.7

470

1624

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

10.3

80.3

163

166

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

8.7

78.0

175

213

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.4

76.9

418

1369

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

9.5

76.6

163

181

XF400

NOMESCO Finland

ECG with 12 standard connections

2.6

76.3

653

2881

Z49.1

ICD-10 Finland

Extracorporeal dialysis

16.0

74.4

123

JN4AD

NOMESCO Finland

Body CT examination

3.9

74.1

332

927

127

Kela drug reimbursment

Transplant complication

15.5

72.3

121

AA1AD

NOMESCO Finland

CT of head and brain

2.3

70.1

826

4280

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

70.1

944

5208

S76

ICPC

Skin infection other

5.1

68.5

229

478

D64.9

ICD-10 Finland

Anaemia, unspecified

3.1

68.4

414

1458

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

4.3

68.2

268

662

XW000

NOMESCO Finland

Bone marrow biopsy

5.2

67.5

222

455

TPX10

NOMESCO Finland

Implantation of vascular injection port

7.6

66.5

161

221

H02AB06

ATC

prednisolone; systemic

2.0

66.4

1397

9208

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

5.0

65.8

222

468

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.6

65.8

325

982

A10AE04

ATC

insulin glargine; parenteral

3.2

65.6

385

1326

C07AB07

ATC

bisoprolol; oral

1.9

65.4

1519

10369

A28

ICPC

Limited function/disability NOS

2.6

64.8

558

2448

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.9

64.0

1446

9736

A02BC02

ATC

pantoprazole; systemic

1.9

64.0

1862

13765

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.3

62.2

340

1109

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.0

62.1

1201

7599

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

620.6

62.0

A11CC03

ATC

alfacalcidol; systemic

8.5

61.5

139

171

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.6

61.5

303

912

B03XA02

ATC

darbepoetin alfa; parenteral

10.0

59.7

122

126

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.1

59.4

798

4335

R06.0

ICD-10 Finland

Dyspnoea

2.1

59.3

808

4414

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.0

58.0

947

5572

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.4

57.7

562

2613

N18.8

ICD-10 Finland

Other chronic renal failure

6.0

57.6

167

294

N02BE01

ATC

paracetamol; systemic, rectal

2.1

56.9

2449

20464

R60.0

ICD-10 Finland

Localized oedema

2.9

56.9

390

1482

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

10.9

56.8

111

105

L04AA06

ATC

mycophenolic acid; systemic

11.8

56.8

107

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.4

55.3

523

2390

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.9

54.6

375

1426

TQW11

NOMESCO Finland

Vacuum treatment of wound

9.1

54.5

118

135

J01MA02

ATC

ciprofloxacin; systemic

1.9

54.0

1170

7604

N02AX02

ATC

tramadol; systemic, rectal

1.9

53.9

1261

8415

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

7.2

53.6

134

193

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.8

53.1

188

416

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

4.5

52.8

197

460

JN3AD

NOMESCO Finland

Abdominal CT examination

3.3

52.7

290

947

M46.3

ICD-10 Finland

Infection of intervertebral disc (pyogenic)

46.6

52.5

J01CF05

ATC

flucloxacillin; systemic

5.3

52.3

168

334

ZZA00

NOMESCO Finland

Split skin graft

5.4

52.2

163

314

103

Kela drug reimbursment

Diabetes, insulin-treated

2.0

51.4

882

5239

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.9

51.3

967

5948

M46.4

ICD-10 Finland

Discitis, unspecified

29.4

51.1

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.3

50.8

278

903

L03AA02

ATC

filgrastim; parenteral

7.0

50.8

129

190

J01CA04

ATC

amoxicillin; systemic

1.9

50.8

2277

18738

A12AA04

ATC

calcium carbonate; oral

9.8

49.5

102

107

SPAT1254

SPAT

Administration of medicine

2.3

49.3

507

2408

WW200

NOMESCO Finland

Immunization

5.7

49.1

147

269

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

5.8

49.1

144

257

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.7

49.0

367

1468

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

14.7

48.9

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

10.9

48.7

H02AB02

ATC

dexamethasone; systemic

2.9

48.6

331

1245

TK810

NOMESCO Finland

Hemofiltration

24.3

48.5

NHQ40

NOMESCO Finland

Amputation of toe

9.2

48.3

103

115

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

7.1

48.1

121

176

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.5

47.7

240

730

EBA15

NOMESCO Finland

Extraction of large number of teeth

4.2

47.5

189

470

N18.0

ICD-10 Finland

End-stage renal disease

11.4

47.3

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.9

47.2

204

547

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

22.4

46.7

SPAT1262

SPAT

Handing over of treatment supplies

2.1

46.3

613

3256

B99

ICD-10 Finland

Other and unspecified infectious diseases

7.4

46.3

113

157

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

4.2

46.2

184

458

WX882

NOMESCO Finland

High dependency care

5.0

46.1

153

316

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.9

46.0

298

1087

WX002

NOMESCO Finland

Sedation and analgesia

2.1

45.5

628

3395

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

5.9

45.1

131

231

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

7.0

44.9

114

168

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.6

44.8

351

1437

S18

ICPC

Laceration/cut

1.8

44.5

1232

8518

L04AD01

ATC

ciclosporin; systemic

8.3

44.1

100

124

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.9

44.1

753

4416

B01AB10

ATC

tinzaparin; parenteral

3.2

44.0

251

839

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

5.8

43.9

128

227

N03AX16

ATC

pregabalin; oral

2.0

43.8

669

3759

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.4

43.4

410

1856

L28

ICPC

Limited function/disability (L)

2.2

43.1

493

2450

TKC20

NOMESCO Finland

Catheterisation of bladder

2.9

43.0

285

1053

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.1

43.0

260

903

J01CE02

ATC

phenoxymethylpenicillin; oral

1.7

43.0

1868

14725

I35.0

ICD-10 Finland

Aortic (valve) stenosis

3.0

42.8

266

942

A40.2

ICD-10 Finland

Sepsis due to streptococcus, group D and enterococcus

+∞

41.8

A03FA01

ATC

metoclopramide; systemic, rectal

2.1

41.5

581

3145

V03AE01

ATC

polystyrene sulfonate; oral

9.6

41.4

A06AD11

ATC

lactulose; oral

2.2

41.3

496

2514

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.8

41.2

144

314

L89

ICD-10 Finland

Decubitus ulcer and pressure area

8.3

41.1

115

C90.0

ICD-10 Finland

Multiple myeloma

9.2

40.9

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.3

40.9

219

698

X59

ICD-10 Finland

Exposure to unspecified factor

2.1

40.7

554

2958

M10.9

ICD-10 Finland

Gout, unspecified

3.0

40.7

253

895

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.9

40.1

263

964

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

3.6

40.0

192

562

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.5

39.4

335

1431

SPAT1263

SPAT

Sampling

1.7

39.3

1205

8493

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.9

39.2

722

4323

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

4.9

38.9

131

275

C08CA01

ATC

amlodipine; oral

1.7

38.8

1075

7348

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

7.0

38.7

144

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

38.7

263

985

03800

ICD-8 Finland

Septicaemia, Streptococcal

+∞

38.6

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

12.1

38.6

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

15.2

38.4

GD1AD

NOMESCO Finland

Thorax CT examination

3.7

38.4

177

501

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

38.3

586

3272

C01AA05

ATC

digoxin; systemic

2.5

37.6

331

1438

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

3.1

37.2

218

740

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

3.3

36.8

197

627

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.0

36.6

225

788

0380A

ICD-9 Finland

Septicaemia, Streptococcal septicaemia[SEPTICHAEMIA STREPTOCOCCUC BETAHAEMOLYTICUS]

+∞

36.5

J86.9

ICD-10 Finland

Pyothorax without fistula

10.2

36.5

A03

ICPC

Fever

2.2

36.2

429

2150

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.5

35.7

300

1271

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

26.2

35.4

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

7.8

35.1

107

WX110

NOMESCO Finland

Local anesthesy

1.6

35.1

1828

14709

Z94.0

ICD-10 Finland

Kidney transplant status

12.6

35.0

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

6.8

34.6

134

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.7

34.6

255

1002

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.7

34.4

248

962

Z49.0

ICD-10 Finland

Preparatory care for dialysis

11.2

34.2

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

34.2

463

2452

I38

ICD-10 Finland

Endocarditis, valve unspecified

77.0

33.9

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.3

33.8

183

587

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

3.0

33.8

203

698

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

11.2

33.7

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

4.3

33.6

130

315

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

12.2

33.4

207

Kela drug reimbursment

Chronic arrhythmias

2.0

33.2

499

2749

Z51.5

ICD-10 Finland

Palliative care

2.9

33.2

208

739

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

33.5

33.1

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.8

33.1

145

393

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.6

33.1

252

1007

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

3.4

33.0

171

531

A04AA01

ATC

ondansetron; systemic, rectal

2.9

32.9

207

737

T90

ICPC

Diabetes non-insulin dependent

1.8

32.7

678

4188

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.1

32.6

408

2091

WX722

NOMESCO Finland

PEEP

3.2

32.5

184

608

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

32.5

1658

13141

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

27.9

32.4

ZXA00

NOMESCO Finland

Right side

1.7

32.3

793

5162

I50

ICD-10 Finland

Heart failure

4.0

32.0

132

339

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

73.0

31.9

G00.1

ICD-10 Finland

Pneumococcal meningitis

114.6

31.7

A07AA09

ATC

vancomycin; oral

9.2

31.3

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.0

31.0

422

2231

J01DA01

ATC

[U] cefalexin; systemic

1.6

30.8

1680

13454

E0000UV

ATC

1.6

30.5

1026

7271

R53

ICD-10 Finland

Malaise and fatigue

1.9

30.4

560

3311

B18.2

ICD-10 Finland

Chronic viral hepatitis C

9.2

30.3

R81

ICPC

Pneumonia

3.8

30.1

131

354

M00.2

ICD-10 Finland

Other streptococcal arthritis and polyarthritis

68.6

29.9

WX730

NOMESCO Finland

Conventional respirator

5.9

29.9

147

R03BB04

ATC

tiotropium bromide; inhalant

2.2

29.7

334

1628

A10BA02

ATC

metformin; oral

1.7

29.7

815

5459

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

9.9

29.6

SPAT1229

SPAT

Assessment of need for aid

2.5

29.6

253

1079

196

Kela drug reimbursment

Paricalcitol and cinacalcet

21.8

29.6

XF600

NOMESCO Finland

Bloodpressure measurement

2.7

29.5

217

848

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

29.5

828

5579

153

Kela drug reimbursment

Lenalidomid

14.6

29.2

137

Kela drug reimbursment

Uraemia requiring dialysis

10.5

29.2

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.0

29.0

176

609

QDA10

NOMESCO Finland

Incision of skin of lower limb

12.9

28.8

D70.82

ICD-10 Finland

Drug-induced neutropenia

8.6

28.7

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

6.5

28.7

120

UJF32

NOMESCO Finland

Coloscopy

1.7

28.7

711

4614

N17.8

ICD-10 Finland

Other acute renal failure

7.7

28.5

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

16.9

28.4

E66.01

ICD-10 Finland

Obesity due to excess calories

2.7

28.2

202

777

H02AB04

ATC

methylprednisolone; systemic

2.0

28.2

399

2140

A10AE05

ATC

insulin detemir; parenteral

2.8

28.0

191

716

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.0

28.0

185

WW300

NOMESCO Finland

Transfer of autologic stem cells

24.7

27.9

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

27.8

371

1943

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

7.7

27.8

K92.1

ICD-10 Finland

Melaena

2.7

27.4

195

749

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

27.3

1180

8837

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.5

27.3

133

395

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

27.1

464

2667

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

27.1

481

2801

205

Kela drug reimbursment

Chronic hypertension

1.6

27.1

860

5961

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

14.1

27.1

R18

ICD-10 Finland

Ascites

5.9

26.9

131

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

3.6

26.8

123

348

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

4.9

26.7

190

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.6

26.7

124

354

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

8.9

26.7

ZX108

NOMESCO Finland

Inhalation

11.3

26.6

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

5.7

26.6

137

V03AE02

ATC

sevelamer; oral

19.3

26.5

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

26.5

727

4840

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

12.5

26.3

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.2

26.2

103

254

L04AX04

ATC

lenalidomide; oral

14.4

26.1

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.8

26.1

172

631

A08

ICPC

Swelling

3.2

26.1

140

447

A41.4

ICD-10 Finland

Sepsis due to anaerobes

+∞

26.1

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

6.2

26.0

117

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.9

26.0

463

2694

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.7

25.8

182

696

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.3

25.7

262

1217

K78

ICPC

Atrial fibrillation/flutter

2.3

25.6

264

1232

N19

ICD-10 Finland

Unspecified kidney failure

3.4

25.6

128

388

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

25.5

405

2262

H02AB09

ATC

hydrocortisone; systemic

4.8

25.5

187

WX725

NOMESCO Finland

Noninvasive ventilation

2.9

25.4

158

558

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

6.7

25.3

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

10.1

25.2

H02AB07

ATC

prednisone; oral

1.9

25.2

391

2164

0350X

ICD-9 Finland

Erysipelas[ERYSIPELAS ALIA DEFINITA SEU NUD]

+∞

25.0

N05CF01

ATC

zopiclone; oral

1.6

24.8

876

6213

A10BH01

ATC

sitagliptin; oral

2.1

24.8

286

1407

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

7.7

24.5

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

4.8

24.5

177

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

4.2

24.5

237

G00.9

ICD-10 Finland

Bacterial meningitis, unspecified

27.8

24.4

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

6.8

24.4

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

12.8

24.3

E87.5

ICD-10 Finland

Hyperkalaemia

5.7

24.3

128

G06.1

ICD-10 Finland

Intraspinal abscess and granuloma

+∞

24.0

ZXA05

NOMESCO Finland

Left side

1.6

24.0

700

4718

M79.6

ICD-10 Finland

Pain in limb

1.6

23.9

884

6326

L04AA01

ATC

[U] ciclosporin; systemic

6.6

23.9

A05AA02

ATC

ursodeoxycholic acid; oral

6.1

23.7

108

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

3.4

23.7

116

346

J04AB02

ATC

rifampicin; systemic

6.5

23.7

J15.4

ICD-10 Finland

Pneumonia due to other streptococci

41.8

23.6

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.8

23.6

157

580

L03.9

ICD-10 Finland

Cellulitis, unspecified

5.0

23.6

158

L17

ICPC

Foot/toe symptom/complaint

1.6

23.5

660

4402

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

4.1

23.4

237

KA1AE

NOMESCO Finland

Kidney ultrasound examination

4.2

23.4

218

A12BA01

ATC

potassium chloride; oral

2.7

23.4

164

625

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

2.5

23.4

190

787

R02

ICPC

Shortness of breath/dyspnoea

2.0

23.2

338

1828

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

4.8

23.1

166

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

5.8

23.1

116

0380X

ICD-9 Finland

Septicaemia, Streptococcal septicaemia[SEPTICHAEMIA STREPTOCOCCUS ALIA]

+∞

22.9

C09AA05

ATC

ramipril; oral

1.6

22.9

721

4949

H05BX01

ATC

cinacalcet; oral

13.1

22.9

WX213

NOMESCO Finland

Lower leg blockade

10.6

22.8

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.9

22.7

146

528

R4120

NOMESCO Finland

Occupational therapy

2.6

22.5

175

706

K07

ICPC

Swollen ankles/oedema

2.9

22.5

141

501

R11

ICD-10 Finland

Nausea and vomiting

2.3

22.5

224

1030

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

22.5

468

2857

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

22.4

836

5978

TFP20

NOMESCO Finland

Cardiodefibrillation

2.1

22.3

254

1241

P01AB01

ATC

metronidazole; oral, rectal

1.5

22.3

915

6687

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.5

22.3

175

713

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

13.7

22.2

WZC30

NOMESCO Finland

Teaching

1.9

22.2

360

2022

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

2.8

22.2

148

548

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

24.1

22.1

E66.8

ICD-10 Finland

Other obesity

3.0

22.1

133

460

ZXA10

NOMESCO Finland

Bilateral

1.7

22.1

519

3285

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.1

22.0

253

1239

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

5.6

22.0

119

R60.9

ICD-10 Finland

Oedema, unspecified

2.8

22.0

142

514

A04AA02

ATC

granisetron; systemic, transdermal

2.7

21.9

155

595

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

13.9

21.8

A10BH05

ATC

linagliptin; oral

2.6

21.7

160

628

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

22.4

21.7

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

8.2

21.6

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.2

21.6

115

366

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.5

21.6

105

312

J01XX08

ATC

linezolid; systemic

12.8

21.6

AN1

Coronary angiography

1.8

21.6

378

2178

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.8

21.5

395

2315

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.4

21.4

192

836

D70.89

ICD-10 Finland

Neutropenic splenomegaly

7.0

21.4

SPAT1301

SPAT

No procedures

1.5

21.4

862

6259

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

9.3

21.3

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.0

21.2

283

1475

NGQ20

NOMESCO Finland

Amputation of lower leg

12.9

21.1

C07AB02

ATC

metoprolol; systemic

1.6

21.1

616

4132

Z49.2

ICD-10 Finland

Other dialysis

10.4

21.1

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

4.6

21.0

165

E66.00

ICD-10 Finland

Metabolic syndrome

2.6

21.0

157

623

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

28.2

20.9

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

4.7

20.9

157

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.9

20.9

326

1805

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.7

20.9

258

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.8

20.8

136

497

B01AF02

ATC

apixaban; oral

2.0

20.8

289

1532

WX320

NOMESCO Finland

Spinalanesthesy

1.6

20.8

603

4037

H3601, E113

ICD-10 Finland

5.1

20.8

132

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

20.8

901

6646

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

5.4

20.7

116

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.5

20.7

286

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

8.2

20.7

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.6

20.6

154

610

A10BB12

ATC

glimepiride; oral

2.1

20.6

241

1191

XCK10

NOMESCO Finland

Photography of fundus of eye

2.0

20.4

295

1585

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

20.4

667

4604

WX212

NOMESCO Finland

Femoral plexus blockade

4.1

20.3

199

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

20.3

208

966

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.0

20.3

119

406

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.1

20.3

116

388

I50.1

ICD-10 Finland

Left ventricular failure

2.4

20.2

171

725

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

11.7

20.2

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

4.0

20.2

210

ZX112

NOMESCO Finland

Subcutaneous

3.9

20.2

215

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

5.4

20.1

112

I33.9

ICD-10 Finland

Acute endocarditis, unspecified

27.2

20.0

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.4

20.0

177

766

L03AA13

ATC

pegfilgrastim; parenteral

3.4

20.0

294

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

3.8

20.0

232

C09AA02

ATC

enalapril; systemic

1.6

20.0

582

3897

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

4.1

19.9

193

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

8.5

19.9

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.2

19.8

203

945

K08.3

ICD-10 Finland

Retained dental root

2.2

19.8

207

973

X57

ICD-10 Finland

Unspecified privation

4.1

19.6

196

Z72.2

ICD-10 Finland

Drug use

16.5

19.6

D65

ICD-10 Finland

Disseminated intravascular coagulation [defibrination syndrome]

201.2

19.6

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

19.5

943

7096

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

7.2

19.5

EBA10

NOMESCO Finland

Surgical removal of tooth

1.9

19.4

287

1556

K70.4

ICD-10 Finland

Alcoholic hepatic failure

15.6

19.2

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

19.1

1114

8696

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

7.5

19.1

V03AE03

ATC

lanthanum carbonate; oral

22.7

19.0

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.9

19.0

119

423

K02.1

ICD-10 Finland

Caries of dentine

1.4

18.9

1377

11213

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

4.0

18.8

189

EBA00

NOMESCO Finland

Extraction of tooth

1.5

18.8

821

6036

A40

ICD-10 Finland

Streptococcal sepsis

+∞

18.8

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.8

18.7

123

451

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.8

18.7

215

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

18.6

845

6260

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

3.2

18.5

100

323

WX704

NOMESCO Finland

Intubation

2.2

18.4

200

956

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.2

18.4

308

L04AX01

ATC

azathioprine; systemic

2.8

18.4

118

428

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

10.1

18.4

B05DA

ATC

Isotonic solutions

9.6

18.3

A07AA02

ATC

nystatin; oral

2.3

18.3

172

770

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

11.9

18.3

C02AC05

ATC

moxonidine; oral

2.5

18.2

145

593

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.7

18.2

220

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.3

18.1

176

800

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

7.1

18.1

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.7

18.1

123

461

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

18.0

927

7040

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

18.0

546

3681

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.2

18.0

190

897

HA1AA

NOMESCO Finland

X-ray mammography

2.4

18.0

151

639

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

10.1

17.9

J96.1

ICD-10 Finland

Chronic respiratory failure

3.6

17.8

224

L84

ICD-10 Finland

Corns and callosities

3.0

17.8

105

360

RD210

NOMESCO Finland

4.0

17.8

185

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.1

17.7

196

945

AB2

AVR bio, stent

6.3

17.7

A04

ICPC

Weakness/tiredness general

1.8

17.6

341

2025

T89

ICPC

Diabetes insulin dependent

2.8

17.6

113

409

L01AA01

ATC

cyclophosphamide; systemic

14.6

17.6

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

3.4

17.6

264

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

17.4

275

1523

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

17.4

605

4214

B01AC04

ATC

clopidogrel; oral

1.6

17.4

469

3067

R03AC02

ATC

salbutamol; inhalant

1.4

17.4

1285

10437

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

6.1

17.4

N05AH04

ATC

quetiapine; oral

1.7

17.4

381

2351

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

17.3

219

1115

B01AB04

ATC

dalteparin; parenteral

2.5

17.3

143

599

M86.6

ICD-10 Finland

Other chronic osteomyelitis

21.0

17.3

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.5

17.2

137

563

SPAT1151

SPAT

Treatment of major wounds

5.2

17.2

103

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

5.9

17.2

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.9

17.2

107

381

B03XA01

ATC

erythropoietin; parenteral

6.5

17.2

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.4

17.1

144

607

S29

ICPC

Skin symptom/complaint other

1.7

17.1

431

2768

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.9

17.0

108

387

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.6

17.0

125

491

NF1AA

NOMESCO Finland

Hip X-ray examination

2.0

17.0

233

1224

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.9

16.9

282

1592

K75.0

ICD-10 Finland

Abscess of liver

17.5

16.9

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.9

16.9

103

361

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

10.1

16.9

6BA02

NOMESCO Finland

22.0

16.8

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.5

16.8

130

526

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

16.8

313

1838

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

35.2

16.7

S91.3

ICD-10 Finland

Open wound of other parts of foot

3.5

16.6

227

GBB00

NOMESCO Finland

Tracheostomy

4.9

16.6

112

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.6

16.6

207

A49.1

ICD-10 Finland

Streptococcal and enterococcal infection, unspecified site

90.5

16.6

J96.0

ICD-10 Finland

Acute respiratory failure

4.5

16.6

130

SPAT1216

SPAT

Assessment of functional ability

1.7

16.5

415

2659

J01CR50

ATC

combinations of penicillins; systemic

170.8

16.5

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

16.5

496

3333

TGC00

NOMESCO Finland

Bronchial lavation

3.3

16.5

261

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

5.3

16.5

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.5

16.4

225

RS220

NOMESCO Finland

4.9

16.3

110

XF404

NOMESCO Finland

Ambulatory ECG

1.9

16.2

260

1450

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

16.2

243

1323

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.0

16.2

223

1176

R04.0

ICD-10 Finland

Epistaxis

2.0

16.1

210

1083

H3603, E113

ICD-10 Finland

6.3

16.1

TQW80

NOMESCO Finland

Local dermatologic skincare

3.1

16.1

294

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

16.0

188

929

K83.0

ICD-10 Finland

Cholangitis

5.2

16.0

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.7

16.0

111

422

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

24.6

16.0

Z94.4

ICD-10 Finland

Liver transplant status

18.6

16.0

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.7

15.9

108

406

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

9.5

15.9

WX402

NOMESCO Finland

General anaesthesia

1.6

15.9

398

2546

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

3.2

15.8

269

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

14.6

15.8

K65.0

ICD-10 Finland

Acute peritonitis

4.9

15.8

105

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.1

15.8

173

832

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

60.3

15.8

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

4.0

15.7

156

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

33.5

15.7

H3603, E103

ICD-10 Finland

6.8

15.7

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.2

15.6

255

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

13.0

15.6

A41.2

ICD-10 Finland

Sepsis due to unspecified staphylococcus

+∞

15.6

N08.0*A40.9

ICD-10 Finland

Glomerular disease in streptococcal septicemia

+∞

15.6

U14

ICPC

Kidney symptom/complaint

4.4

15.6

129

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.7

15.6

182

E000001

ATC

1.6

15.5

493

3352

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

2.4

15.5

129

543

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

15.5

315

1895

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.0

15.5

301

M13.9

ICD-10 Finland

Arthritis, unspecified

2.1

15.4

177

870

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

38.2

15.4

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

38.2

15.4

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

7.7

15.3

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

15.3

194

991

A02BC01

ATC

omeprazole; systemic

1.5

15.3

722

5358

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

4.8

15.2

105

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.1

15.2

277

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

15.2

825

6286

D07AA02

ATC

hydrocortisone; topical

1.7

15.2

333

2051

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

15.1

407

2653

D09AB01

ATC

zinc bandage without supplements; topical

3.8

15.1

167

J46

ICD-10 Finland

Status asthmaticus

3.1

15.1

262

I44.2

ICD-10 Finland

Atrioventricular block, complete

2.9

15.1

336

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.2

15.0

150

691

SPAT1211

SPAT

Application of soft bandage

1.9

15.0

246

1381

E66.9

ICD-10 Finland

Obesity, unspecified

3.1

15.0

269

Z71.8

ICD-10 Finland

Other specified counselling

1.5

15.0

549

3858

N05CD07

ATC

temazepam; oral

1.7

15.0

341

2124

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.4

14.9

131

568

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.1

14.8

171

841

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.8

14.8

165

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.0

14.8

202

1064

K72.9

ICD-10 Finland

Hepatic failure, unspecified

11.3

14.7

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

16.5

14.7

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

7.2

14.7

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

4.2

14.7

132

C01DA14

ATC

isosorbide mononitrate; oral

1.6

14.7

477

3257

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

6.4

14.7

D07AC01

ATC

betamethasone; topical

1.4

14.7

829

6356

E000006

ATC

2.1

14.7

174

866

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.1

14.6

263

A49.0

ICD-10 Finland

Staphylococcal infection, unspecified site

+∞

14.6

PBU84

NOMESCO Finland

Plastic repair of arteriovenous fistula from artery of upper extremity

80.5

14.6

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

14.5

405

2666

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.2

14.4

243

JN4CD

NOMESCO Finland

Very extensive body CT

2.4

14.4

121

511

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

14.4

716

5358

3AC01

NOMESCO Finland

5.2

14.4

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.9

14.3

155

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

7.9

14.3

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

5.1

14.2

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.0

14.2

183

943

GD1LA

NOMESCO Finland

3.9

14.2

147

UKC02

NOMESCO Finland

Cystoscopy

1.5

14.1

473

3250

B34.9

ICD-10 Finland

Viral infection, unspecified

3.1

14.1

258

L03.3

ICD-10 Finland

Cellulitis of trunk

7.7

14.1

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.6

14.0

106

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

14.0

273

1623

P15

ICPC

Chronic alcohol abuse

3.1

14.0

254

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

10.1

13.9

NFQ20

NOMESCO Finland

Amputation of femur

6.1

13.9

J05AB11

ATC

valaciclovir; oral

1.7

13.9

303

1860

N03AG01

ATC

valproic acid; systemic, rectal

2.2

13.9

142

662

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

12.7

13.9

M72.6

ICD-10 Finland

Necrotizing fasciitis

30.2

13.9

120

Kela drug reimbursment

Hypogammaglobulinaemia

30.2

13.9

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.5

13.9

108

438

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

4.2

13.8

126

WW402

NOMESCO Finland

Leucoferesis

53.6

13.8

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.7

13.8

JJC00

NOMESCO Finland

Allogenic transplantation of liver

23.9

13.8

E86

ICD-10 Finland

Volume depletion

3.2

13.8

235

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

6.7

13.7

GAC97

NOMESCO Finland

Other endoscopic operation on pleura

13.6

13.7

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

2.9

13.7

287

N05BA01

ATC

diazepam; systemic, rectal

1.6

13.6

334

2118

L30.3

ICD-10 Finland

Infective dermatitis

2.6

13.6

383

N08.0*A41.9

ICD-10 Finland

Glomerular disease in unspecified septicemia

+∞

13.5

ED1AA

NOMESCO Finland

Mandipular X-ray examination

7.2

13.5

RJ411

NOMESCO Finland

8.4

13.5

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.8

13.5

149

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

16.3

13.4

K77

ICPC

Heart failure

3.3

13.4

212

R33

ICD-10 Finland

Retention of urine

1.8

13.4

236

1358

H3600, E113

ICD-10 Finland

4.2

13.3

121

PE1AT

NOMESCO Finland

Femoral artery PTA

4.1

13.3

126

YNB10

NOMESCO Finland

Collection of stem cells for transplant

21.2

13.3

N05BA04

ATC

oxazepam; oral

1.5

13.3

574

4163

K83

ICPC

Heart valve disease NOS

4.7

13.3

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

11.5

13.3

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.5

13.2

182

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

4.4

13.2

108

C03AA03

ATC

hydrochlorothiazide; oral

1.7

13.2

266

1597

XFE00

NOMESCO Finland

Epicardial ultrasonography

2.7

13.2

353

G47.3

ICD-10 Finland

Sleep apnoea

1.5

13.2

508

3598

329

Kela drug reimbursment

Lenalidomide

10.5

13.2

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.2

13.2

130

597

A10BJ06

ATC

semaglutide; parenteral

2.8

13.2

306

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

5.3

13.1

P19

ICPC

Drug abuse

6.9

13.1

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

5.9

13.1

N06AX11

ATC

mirtazapine; oral

1.4

13.1

736

5620

J02AC01

ATC

fluconazole; systemic

1.4

13.1

776

5979

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

15.1

13.1

WVA20

NOMESCO Finland

Medicine administration

3.3

13.1

200

212

Kela drug reimbursment

Gout

3.1

13.1

233

N03AX12

ATC

gabapentin; oral

1.6

13.0

348

2260

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.0

13.0

174

908

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.3

13.0

206

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.6

13.0

351

M46.2

ICD-10 Finland

Osteomyelitis of vertebra

28.5

12.9

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

9.4

12.9

S19

ICPC

Skin injury other

2.4

12.9

112

484

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

22.6

12.9

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.7

12.9

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.1

12.8

144

699

A29

ICPC

General symptom/complaint other

1.7

12.8

275

1680

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

5.5

12.8

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

11.6

12.8

F10.24

ICD-10 Finland

Alcohol depence active use

4.2

12.8

112

C08CA13

ATC

lercanidipine; oral

1.6

12.7

339

2200

N07BB01

ATC

disulfiram; oral

2.3

12.7

113

492

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.6

12.7

354

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

9.7

12.7

S17

ICPC

Abrasion/scratch/blister

2.9

12.7

276

M05BX04

ATC

denosumab; parenteral

2.3

12.7

119

535

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

5.6

12.7

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

6.8

12.7

S91.1

ICD-10 Finland

Open wound of toe(s) without damage to nail

4.1

12.6

118

XX3DW

NOMESCO Finland

Time consuming IT work

1.7

12.5

256

1543

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

5.7

12.5

WW306

NOMESCO Finland

Transfer of stem cells from foreign registered donator

+∞

12.5

TK820

NOMESCO Finland

Peritoneal dialysis

10.1

12.5

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

4.4

12.5

101

M10

ICD-10 Finland

Gout

2.2

12.5

120

546

L14

ICPC

Leg/thigh symptom/complaint

1.9

12.5

182

984

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

20.1

12.4

QD6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in foot

20.1

12.4

RS221

NOMESCO Finland

4.0

12.4

125

E87.6

ICD-10 Finland

Hypokalaemia

2.8

12.4

282

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.1

12.4

214

D07BC01

ATC

betamethasone and antiseptics; topical

1.7

12.4

290

1819

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.0

12.3

121

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

4.9

12.3

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.2

12.3

126

588

B05DB

ATC

Hypertonic solutions

8.4

12.2

AA1AA

NOMESCO Finland

Head X-ray examination

5.7

12.2

S70

ICPC

Herpes zoster

3.0

12.2

238

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

12.2

251

1518

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

12.1

272

1684

D07AB08

ATC

desonide; topical

1.7

12.1

247

1487

RJ414

NOMESCO Finland

12.4

12.1

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.5

12.1

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.5

12.1

391

R4190

NOMESCO Finland

Nutritional therapy

2.5

12.1

391

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

12.1

649

4905

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

5.6

12.1

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

12.0

424

2942

M14.6*E10.6

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic neuropathic

26.8

12.0

RJ420

NOMESCO Finland

11.1

12.0

R52.0

ICD-10 Finland

Acute pain

2.8

12.0

283

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

4.6

12.0

5CM18

NOMESCO Finland

9.3

12.0

SPAT1104

SPAT

Monitoring of emergency patient

1.9

11.9

172

925

QXB10

NOMESCO Finland

Exchange of dressing for large skin wound, unspecified location

13.4

11.9

M10.0

ICD-10 Finland

Idiopathic gout

2.5

11.9

380

I34.1

ICD-10 Finland

Mitral (valve) prolapse

2.6

11.9

344

160

Kela drug reimbursment

exenatide

3.4

11.9

166

N05BA06

ATC

lorazepam; systemic, sublingual

2.1

11.9

135

660

N30.0

ICD-10 Finland

Acute cystitis

1.6

11.9

290

1839

K70

ICPC

Infection of circulatory system

46.8

11.9

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

4.9

11.9

-50

ICPC

Medication/prescr/renewal

2.2

11.9

118

544

E000003

ATC

2.3

11.8

112

505

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.1

11.7

206

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.4

11.7

163

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.0

11.7

151

779

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

16.5

11.7

9861/3-C42.1

ICD-O-3

Acute myeloid leukemia, NOS, of bone marrow

16.5

11.7

NGS10

NOMESCO Finland

Incision and debridement of infection of knee joint

16.5

11.7

M86.4

ICD-10 Finland

Chronic osteomyelitis with draining sinus

30.1

11.6

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

3.0

11.6

213

SPAT1265

SPAT

Breathalyser

6.0

11.6

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

12.6

11.6

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.6

11.6

329

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

19.0

11.6

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

23.0

11.6

3A064

NOMESCO Finland

8.1

11.5

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

6.5

11.5

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.7

11.5

282

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.9

11.5

119

FKD00

NOMESCO Finland

Replacement of mitral valve using mechanical prosthesis

11.1

11.5

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.8

11.5

129

0380C

ICD-9 Finland

Septicaemia, Streptococcal septicaemia[SEPTICHAEMIA ENTEROCOCCUS]

+∞

11.5

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

2.9

11.4

238

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

4.3

11.4

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

11.4

215

1262

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

11.4

436

3076

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.4

11.4

161

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.7

11.4

286

R31

ICD-10 Finland

Unspecified haematuria

1.6

11.3

284

1814

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

10.6

11.2

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

10.6

11.2

L70

ICPC

Infection of musculoskeletal system

8.9

11.2

A10BJ02

ATC

liraglutide; parenteral

3.2

11.2

185

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

11.2

527

3879

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

2.6

11.1

326

3A422

NOMESCO Finland

25.1

11.1

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.8

11.1

247

S01.0

ICD-10 Finland

Open wound of scalp

1.8

11.1

198

1145

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

3.5

11.1

144

128

Kela drug reimbursment

Cancers of female genital organs

4.3

11.0

PD5AD

NOMESCO Finland

CT of aorta

3.4

11.0

155

SPAT1172

SPAT

Guidance concerning hydration

2.9

11.0

233

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

11.0

152

806

SPAT1260

SPAT

Consultation of another employee

1.5

11.0

433

3075

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

13.9

11.0

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

3.9

10.9

115

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

3.7

10.9

125

A10AA02

ATC

2.3

10.9

440

K99

ICPC

Cardiovascular disease other

2.5

10.9

325

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

6.9

10.8

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

10.8

187

1073

D01AC02

ATC

miconazole; topical

1.7

10.8

206

1217

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

4.4

10.8

321

Kela drug reimbursment

Paricalcitol and cinacalcet

7.2

10.7

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

28.1

10.7

R41.0

ICD-10 Finland

Disorientation, unspecified

2.4

10.7

359

S21

ICPC

Skin texture symptom/complaint

1.6

10.7

301

1981

SPAT1234

SPAT

Support of social functional capacity

2.0

10.7

129

650

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.8

10.6

113

A49

ICD-10 Finland

Bacterial infection of unspecified site

12.9

10.6

GD1UN

NOMESCO Finland

Lung circulation SPECT

6.3

10.6

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

3.3

10.6

155

A10AA01

ATC

2.7

10.6

260

L03AA14

ATC

lipegfilgrastim; parenteral

3.7

10.5

124

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

5.5

10.5

GD2SN

NOMESCO Finland

Lung ventilation SPECT

5.7

10.5

R10.0

ICD-10 Finland

Acute abdomen

2.5

10.5

311

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

10.5

238

1480

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.8

10.5

232

NA1DG

NOMESCO Finland

Cervical spine very extensive MRI examination with high intensity magnet

14.2

10.5

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

14.2

10.5

HAC20

NOMESCO Finland

Total mastectomy

2.5

10.5

339

SPAT1167

SPAT

Insertion of urinary catheter

2.3

10.5

429

RS222

NOMESCO Finland

4.2

10.4

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

10.4

133

685

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

7.7

10.4

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

4.8

10.4

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

10.4

174

989

H62.0*A46

ICD-10 Finland

Otitis externa in erysipelas

16.1

10.3

A07AA11

ATC

rifaximin; oral

16.1

10.3

PD5BD

NOMESCO Finland

Extensive CT of aorta

2.8

10.3

236

WW409

NOMESCO Finland

Other aferesis

12.1

10.3

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.5

10.3

335

R06AE07

ATC

cetirizine; oral

1.3

10.3

955

7847

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.4

10.3

385

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.8

10.3

230

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

10.6

10.3

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

23.4

10.2

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

2.3

10.2

388

N03AX09

ATC

lamotrigine; oral

2.3

10.2

408

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

2.1

10.2

120

597

115

Kela drug reimbursment

Breast cancer

1.9

10.1

139

734

SPAT1275

SPAT

Drug rehabilitation and replacement therapy of opioid-dependent person

6.2

10.1

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

6.2

10.1

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.3

10.1

414

I25.2

ICD-10 Finland

Old myocardial infarction

1.7

10.1

203

1218

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

5.9

10.1

WX890

NOMESCO Finland

Intesive care monitoring

4.4

10.1

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

3.6

10.1

124

J20

ICD-10 Finland

Acute bronchitis

1.7

10.1

211

1282

J01FA06

ATC

roxithromycin; oral

1.3

10.0

940

7731

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

10.0

246

1561

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

10.1

10.0

NH2AA

NOMESCO Finland

Heel X-ray examination

7.2

10.0

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

4.7

9.9

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

9.9

149

813

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

9.9

234

1472

W19

ICD-10 Finland

Unspecified fall

1.6

9.9

229

1432

D01AE15

ATC

terbinafine; topical

1.8

9.9

173

994

H26.3

ICD-10 Finland

Drug-induced cataract

6.7

9.9

J80

ICD-10 Finland

Adult respiratory distress syndrome

7.6

9.9

S20

ICPC

Corn/callosity

2.9

9.9

196

X58

ICD-10 Finland

Exposure to other specified factors

1.5

9.9

302

2026

M86.1

ICD-10 Finland

Other acute osteomyelitis

16.7

9.9

NH1AD

NOMESCO Finland

Ankle and foot CT

3.2

9.9

153

N03AE01

ATC

clonazepam; systemic

1.9

9.9

139

743

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.9

9.8

137

729

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

3.5

9.8

127

J96.9

ICD-10 Finland

Respiratory failure, unspecified

6.0

9.8

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

7.0

9.8

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

8.7

9.8

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

4.5

9.7

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.0

9.7

121

616

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

4.0

9.7

K28

ICPC

Limited function/disability (K)

2.7

9.7

229

WX870

NOMESCO Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1300

3861

4.86

307.65

2.6

1.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

514

763

7.77

307.65

2.3

1.7

3.8

1.6

ug/l

3.11

467

636

(3042936) Bacteria identified in Isolate by Culture

1147

3147

5.01

307.65

3.3

1.8

—

(3023368) Bacteria identified in Blood by Culture

2229

6227

8.65

307.65

9.5

3.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

938

2679

4.47

299.97

2.3

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

937

2678

4.46

299.31

2.4

1.7

—

(42870588) Differential panel, method unspecified - Blood

1845

8434

3.63

294.82

10.1

5.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

829

2182

4.72

294.03

14.1

5.7

12.0

9.7

mmol/l

12.66

794

2058

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

671

1516

5.28

285.75

2.3

1.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1023

3217

4.13

285.70

11.9

4.7

1.1

1.0

mmol/l

7.12

960

2956

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1129

3905

3.85

273.55

5.4

3.0

0.8

mmol/l

5.58

1052

3614

(3007853) Bacteria identified in Skin by Aerobe culture

892

2644

4.23

268.62

2.8

1.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

256

207

13.30

263.37

8.0

6.1

11.7

11.5

mg/l

0.21

235

191

(3019069) Monocytes/100 leukocytes in Blood

2169

11657

3.42

253.80

11.4

5.6

8.5

8.8

3.95

2086

10827

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

914

2869

4.00

252.63

5.4

3.8

251.9

241.9

u/l

1.02

874

2689

(3022096) Basophils/100 leukocytes in Blood

2117

11241

3.38

252.19

11.0

5.4

0.6

0.7

12.93

2024

10404

(3006504) Eosinophils/100 leukocytes in Blood

2156

11595

3.39

250.94

11.1

5.3

2.6

2.9

10.53

2069

10718

(3002030) Lymphocytes/100 leukocytes in Blood

2186

11978

3.36

243.95

11.1

5.4

23.1

28.1

63.43

2095

11061

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

433

778

6.24

234.78

3.7

2.6

0.3

u/ml

2.71

264

420

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

312

393

8.65

234.18

1.7

1.6

—

(3018010) Neutrophils/100 leukocytes in Blood

2141

11811

3.24

231.59

10.7

5.2

61.5

56.9

45.03

2049

10961

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2278

13046

3.31

230.57

11.5

5.3

12.1

12.3

umol/l

0.21

2200

12322

(3001604) Monocytes [#/volume] in Blood

2194

12388

3.22

225.62

10.6

5.1

0.6

e9/l

11.46

1943

10543

(3006315) Basophils [#/volume] in Blood

2198

12445

3.21

224.50

10.7

5.1

0.0

e9/l

0.82

1949

10605

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

968

3403

3.59

223.18

4.3

2.3

20.3

23.4

8.32

845

2885

(3019198) Lymphocytes [#/volume] in Blood

2229

12753

3.22

222.91

10.7

5.2

1.7

2.0

e9/l

3.89

1992

11079

(3027945) Reticulocytes/100 erythrocytes in Blood

899

3033

3.68

220.48

3.6

2.3

1.9

1.7

8.36

805

2643

(3012544) pH of Venous blood

792

2456

3.91

219.97

7.0

3.5

7.4

—

(3013115) Eosinophils [#/volume] in Blood

2235

12888

3.19

218.79

11.3

5.3

0.2

e9/l

1.05

2005

11147

(3004789) Transferrin [Mass/volume] in Serum or Plasma

988

3637

3.43

210.36

4.2

2.2

2.3

g/l

14.13

933

3353

(3021447) Carbon dioxide [Partial pressure] in Venous blood

760

2363

3.86

209.43

7.0

3.4

5.8

5.9

kpa

1.33

729

2303

(3002032) Base excess in Venous blood by calculation

756

2355

3.85

207.62

7.0

3.4

1.5

1.9

mmol/l

1.84

630

1883

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

346

572

6.63

203.12

2.2

1.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1026

3957

3.29

201.31

4.3

2.2

10.5

13.4

umol/l

30.02

961

3644

(3005719) IgG [Mass/volume] in Serum or Plasma

605

1657

4.23

198.41

4.2

2.5

11.5

10.7

g/l

2.37

561

1510

(3032080) INR in Blood by Coagulation assay

1961

10907

2.91

197.32

19.2

9.0

1.4

1.3

inr

3.04

574

3061

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

845

2927

3.52

196.73

10.1

6.7

5.0

5.1

kpa

1.11

786

2789

(3013650) Neutrophils [#/volume] in Blood by Automated count

2363

14549

3.10

196.40

17.1

7.4

4.8

4.1

e9/l

22.89

2132

12501

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

302

448

7.31

196.23

1.5

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

302

448

7.31

196.23

1.5

1.2

—

(3027801) Oxygen [Partial pressure] in Arterial blood

844

2928

3.51

195.95

10.1

6.7

10.8

12.5

kpa

22.66

786

2789

(3003396) Base excess in Arterial blood by calculation

836

2912

3.49

192.53

10.2

6.8

1.1

1.0

mmol/l

0.34

664

2258

(3024561) Albumin [Mass/volume] in Serum or Plasma

1962

11069

2.85

189.43

10.0

4.2

32.0

35.7

g/l

105.34

1850

10210

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

474

1124

4.74

186.70

2.3

1.6

1.4

g/l

3.45

411

941

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

295

450

7.09

186.66

2.0

1.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

514

1305

4.47

185.68

1.6

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

508

1290

4.46

183.37

2.4

1.9

1.3

1.4

g/l

0.25

462

1177

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

245

319

8.21

178.19

7.0

6.4

817.0

371.2

iu/ml

0.41

(3000991) Gas panel - Venous blood

672

2139

3.68

176.57

12.8

7.7

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2001

11738

2.74

173.36

13.5

5.2

1.2

mmol/l

21.35

1884

10495

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

282

443

6.86

173.36

2.0

1.5

—

(3023520) Reticulocytes [#/volume] in Blood

691

2281

3.55

171.38

3.6

2.3

71.2

66.9

e9/l

1.88

527

1709

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2130

12981

2.75

169.45

15.4

5.8

1.2

mmol/l

18.06

1838

10899

(3014111) Lactate [Moles/volume] in Serum or Plasma

662

2162

3.57

166.58

9.8

6.9

1.5

1.4

mmol/l

1.77

631

2087

(3018677) aPTT in Platelet poor plasma by Coagulation assay

980

4068

2.99

164.89

3.2

2.0

31.1

29.8

6.43

954

3945

(3023183) Ammonium ion [Moles/volume] in Plasma

271

433

6.72

163.77

4.3

2.7

34.9

35.7

umol/l

0.18

242

367

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

468

1236

4.24

159.47

7.2

3.8

23.7

24.1

mmol/l

1.25

425

1114

(3016502) Oxygen saturation in Arterial blood

738

2649

3.29

159.12

10.9

7.1

94.5

95.7

4.23

709

2546

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1335

6630

2.68

158.17

2.9

2.1

3.4

2.9

mg/l

9.56

1156

5577

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

655

2225

3.41

154.08

3.0

2.1

0.2

g/l

12.75

603

2073

(3020630) Protein [Mass/volume] in Serum or Plasma

626

2094

3.44

150.67

4.1

2.4

65.9

66.7

g/l

1.34

578

1898

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

355

796

4.87

148.61

2.8

2.1

493.3

399.3

ug/l

0.38

339

752

(3013826) Glucose [Moles/volume] in Serum or Plasma

2336

15458

2.67

148.13

10.4

4.2

7.2

6.8

mmol/l

14.56

2242

14442

(3024354) Oxygen [Partial pressure] in Venous blood

594

1977

3.43

143.67

5.3

3.0

4.9

4.5

kpa

3.25

567

1926

(46235355) HIV 1 and 2 tests - Meaningful Use set

851

3518

2.90

141.64

2.1

1.7

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

306

631

5.23

141.15

1.5

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

187

241

8.16

136.79

3.7

3.8

927.2

1170.1

u/ml

0.09

(3002582) Erythrocytes [#/volume] in Urine

1465

8028

2.46

136.20

4.7

3.1

107.9

85.8

e6/l

0.19

1206

6147

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

481

1455

3.69

134.28

2.2

1.6

—

(3026008) Bacteria identified in Urine by Culture

1379

7434

2.45

131.93

4.1

3.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

212

328

6.83

131.73

2.0

1.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1420

7766

2.43

131.45

5.4

2.9

42.1

34.0

u/l

0.99

1334

7364

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

501

1580

3.55

131.15

6.2

3.3

1.8

1.7

mmol/l

0.23

385

1114

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

205

312

6.93

129.34

1.7

1.4

—

(3017181) Myelocytes/100 leukocytes in Blood

573

1984

3.28

129.12

4.8

3.8

1.0

0.8

1.62

275

478

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1442

8021

2.40

127.52

4.5

2.9

3101.6

1379.1

ng/l

14.25

1288

6855

(3030467) Casts [#/volume] in Urine by Automated count

1351

7302

2.42

127.50

4.6

3.0

0.7

0.4

e6/l

2.90

1097

5470

(3009343) pH of Capillary blood

505

1631

3.47

127.19

6.5

3.5

7.4

0.28

179

(3002173) Hemoglobin [Mass/volume] in Arterial blood

650

2445

3.06

127.04

11.8

7.4

114.4

122.9

g/l

20.49

628

2342

(3026782) Osmolality of Urine

1062

5164

2.54

126.06

3.9

2.5

524.3

566.0

mosm/kgh2o

8.37

953

4347

(3004809) Band form neutrophils/100 leukocytes in Blood

204

320

6.72

125.04

3.6

3.4

1.7

1.8

0.08

174

237

(3019060) Gas panel - Arterial blood

505

1654

3.42

124.26

6.6

4.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

506

1661

3.41

124.05

6.5

3.4

5.1

kpa

1.04

478

1528

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

294

657

4.81

123.04

3.3

2.6

3.9

3.4

g/l

2.83

278

627

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1397

7774

2.36

122.12

3.8

2.3

52.6

59.8

u/l

7.12

1305

7125

(3014576) Chloride [Moles/volume] in Serum or Plasma

765

3211

2.79

121.75

11.9

6.4

103.9

104.6

mmol/l

3.07

749

3133

(3031040) Bacteria [#/volume] in Urine by Automated count

2415

16999

2.49

121.65

6.7

4.2

336.3

1970.3

e6/l

2.11

252

(3004588) Protein electrophoresis panel - Serum or Plasma

512

1717

3.34

121.13

4.1

2.2

—

(3018095) Leukocytes [#/volume] in Urine

1572

9243

2.32

120.30

5.4

3.5

96.4

104.7

e6/l

0.18

1246

6572

(3044640) Blood type and Crossmatch panel - Blood

1416

7972

2.34

119.95

4.7

2.2

—

(3033658) Prothrombin time (PT) actual/Normal

1222

6454

2.40

119.92

8.3

3.6

80.6

87.3

14.33

1190

6307

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

319

779

4.42

119.40

2.7

2.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

183

269

7.14

119.14

1.7

1.4

—

(36304419) Bacteria [Presence] in Urine

1302

7114

2.35

117.75

4.6

2.9

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

435

1345

3.57

116.77

11.7

9.1

24.3

mmol/l

0.04

397

1259

(3037756) Immunofixation for Serum or Plasma

245

492

5.29

116.07

2.1

1.6

—

(3000850) Epithelial cells [#/volume] in Urine

1094

5566

2.43

116.06

3.9

2.4

6.9

4.6

e6/l

3.78

1010

4840

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

483

1616

3.32

114.36

10.2

7.5

24.6

24.8

mmol/l

0.53

478

1604

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

166

233

7.44

112.62

1.7

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

307

769

4.29

110.98

5.4

3.3

75.2

131.0

mg/l

0.34

245

617

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

307

769

4.29

110.98

5.4

3.3

58.2

64.3

mg/l

0.11

242

618

(3008757) Leukocyte morphology finding [Identifier] in Blood

152

196

8.07

110.96

3.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

175

266

6.89

110.38

1.9

1.5

—

(3002179) Metamyelocytes/100 leukocytes in Blood

511

1808

3.15

110.01

4.7

3.6

0.9

0.6

1.42

204

347

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

301

748

4.32

109.93

5.3

3.2

2.8

ratio

0.01

(3018418) pH of Serum or Plasma

1339

7573

2.28

109.86

9.1

3.4

7.4

2.37

290

1390

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

653

2689

2.77

106.52

5.0

2.6

10.3

8.8

umol/l

0.95

545

2363

(3017143) Hepatitis C virus Ab [Presence] in Serum

600

2366

2.87

106.23

2.1

1.5

—

(40758558) Short blood count panel - Blood

1165

6286

2.31

106.23

12.4

5.6

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1678

10502

2.19

106.02

4.7

2.6

220.3

132.5

ug/l

13.32

1566

9587

(3021440) Promyelocytes/100 leukocytes in Blood

523

1914

3.05

105.98

4.9

3.8

0.1

0.42

256

446

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1839

11941

2.19

105.70

7.3

3.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

683

2908

2.69

104.16

2.1

1.5

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2638

19986

2.48

102.28

16.4

6.3

92.7

78.3

u/l

28.01

2551

18682

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

162

246

6.87

102.22

1.7

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

278

704

4.21

98.81

2.9

2.5

85.5

91.0

2.69

265

672

(3009445) Proteinase 3 Ab [Units/volume] in Serum

328

940

3.76

98.07

1.4

1.5

24.6

12.0

u/ml

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

146

210

7.22

96.81

2.0

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

118

133

9.16

95.90

1.2

1.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1337

7924

2.14

93.99

2.8

2.1

220.4

228.5

u/l

0.11

1261

7408

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

991

5220

2.27

93.62

2.3

1.7

2.0

1.3

mg/l

4.41

820

3926

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

417

1439

3.17

92.91

13.9

9.1

—

(3011412) CD3 cells [#/volume] in Blood

126

164

7.94

91.16

2.9

2.5

1.2

1.1

e9/l

0.60

(40760888) Immunoglobulin light chains.free panel - Serum

239

576

4.39

90.51

5.7

3.4

—

(3021589) Normoblasts [#/volume] in Blood

1722

11353

2.06

89.66

19.9

8.5

0.0

e9/l

0.31

1431

9269

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

983

5244

2.24

89.38

5.4

3.6

393.2

725.1

ng/l

0.98

850

4256

(3004119) Hemoglobin [Mass/volume] in Venous blood

426

1527

3.05

88.73

5.4

3.0

117.5

130.9

g/l

23.40

416

1486

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1098

6181

2.15

86.74

4.5

2.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1163

6698

2.13

86.53

4.6

2.5

1240.1

6110.7

umol/l

8.72

1037

5738

(3024891) Influenza virus A+B Ag [Presence] in Specimen

229

564

4.28

84.22

1.3

1.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2371

17806

2.12

83.76

6.5

3.9

—

(3022217) INR in Platelet poor plasma by Coagulation assay

749

3671

2.34

82.53

34.0

25.6

1.5

1.4

inr

0.74

531

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

593

2630

2.52

81.49

6.0

3.0

—

(3022313) Gas panel - Capillary blood

356

1206

3.18

81.44

7.0

3.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

313

983

3.41

81.01

2.9

1.7

—

(3027315) Oxygen [Partial pressure] in Blood

215

521

4.34

80.72

7.2

4.1

8.3

8.5

kpa

0.63

209

510

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

224

563

4.19

80.14

1.7

1.6

—

(3013290) Carbon dioxide [Partial pressure] in Blood

214

521

4.32

79.85

7.3

4.1

5.0

kpa

0.16

208

510

(3012501) Base excess in Blood by calculation

214

521

4.32

79.85

7.3

4.1

2.6

mmol/l

0.09

162

338

(3008152) Bicarbonate [Moles/volume] in Arterial blood

422

1602

2.87

78.84

10.0

6.1

24.4

24.5

mmol/l

0.07

392

1484

(3025159) Blasts/100 leukocytes in Blood

458

1823

2.75

78.18

5.1

3.9

0.1

0.4

0.65

217

375

(3000494) Fungus identified in Specimen by Culture

607

2773

2.45

77.97

1.8

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

543

2357

2.55

77.82

4.7

2.7

353.2

192.3

ng/l

7.98

496

2152

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

424

1625

2.84

77.77

13.6

8.6

0.6

0.7

0.56

418

1619

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

457

1827

2.74

77.31

7.2

3.4

136.4

82.9

ng/l

11.44

405

1559

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

238

643

3.91

77.07

3.1

2.7

224.9

182.9

7.46

231

615

(3021879) Hepatitis B virus core Ab [Presence] in Serum

397

1482

2.90

76.40

1.5

1.4

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

422

1633

2.81

75.93

13.6

8.5

1.4

1.3

1.70

416

1627

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

298

946

3.36

75.69

4.0

2.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

298

946

3.36

75.69

4.0

2.1

4.2

3.8

g/l

1.63

208

677

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

298

947

3.36

75.56

4.0

2.1

7.6

7.2

g/l

2.30

217

706

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

222

579

4.03

75.48

1.5

1.2

5.1

10.9

iu/ml

—

(3019309) Folate [Moles/volume] in Red Blood Cells

920

5060

2.13

75.41

2.1

1.7

1221.0

1160.9

nmol/l

0.89

722

3748

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

101

127

8.17

75.16

2.7

2.5

12.1

13.4

0.27

(1175426) CD3 cells/100 lymphocytes in Blood

101

129

8.04

74.18

2.7

2.5

72.6

69.9

0.54

122

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

797

4177

2.19

73.72

3.8

2.9

2.5

1.9

e6/l

1.00

452

2302

(44790049)

132

227

6.01

73.60

1.8

1.5

—

(44790048)

132

227

6.01

73.60

1.8

1.5

—

(44790047)

132

227

6.01

73.60

1.8

1.5

—

(44806118)

132

227

6.01

73.60

1.8

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

287

907

3.37

73.37

2.7

1.6

—

(3010421) pH of Blood

228

620

3.87

73.10

7.4

3.8

7.4

0.03

211

510

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

183

423

4.52

72.91

1.6

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

833

4463

2.15

72.71

3.6

2.7

1.5

1.1

e6/l

1.74

493

2565

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

105

144

7.49

72.55

2.0

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

283

894

3.36

72.37

3.8

2.1

11.7

10.2

g/l

2.10

236

749

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

217

577

3.95

71.79

2.2

1.5

0.3

0.2

g/l

1.43

201

549

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

244

708

3.64

71.14

1.6

1.5

120.0

337.3

titre

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

220

595

3.89

71.05

2.2

1.5

1.2

g/l

0.34

206

564

(3036489) Thrombin time

277

877

3.35

70.55

2.7

2.2

22.1

21.7

0.53

251

791

(3024928) Oxygen saturation in Venous blood

203

521

4.08

70.50

4.7

3.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

334

1184

3.02

70.34

6.0

2.9

25.2

25.1

mmol/l

0.21

325

1149

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

171

387

4.60

69.93

1.7

1.4

103.5

122.4

u/ml

0.85

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

196

495

4.14

69.56

1.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

120

8.03

69.05

3.0

2.5

606.9

440.5

e6/l

1.98

100

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

309

1060

3.11

68.86

7.4

3.7

24.8

24.7

mmol/l

0.15

289

983

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

115

8.20

68.78

3.0

2.6

0.2

e9/l

0.04

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

117

8.06

67.80

2.7

2.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

10.21

67.38

34.9

22.5

120.6

124.3

ug/l

0.13

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

172

404

4.43

67.11

1.4

1.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1495

10055

1.88

66.69

6.2

3.5

51.6

57.7

ng/l

0.37

1226

7184

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

115

191

6.20

66.39

2.0

1.5

—

(3028626) Oxygen [Partial pressure] in Capillary blood

229

667

3.61

66.32

5.3

3.7

8.3

8.5

kpa

0.95

220

624

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

121

212

5.88

66.16

2.0

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

271

883

3.25

65.78

4.0

2.2

3.4

3.0

g/l

6.93

211

697

(1616796) Gas panel - Central venous blood

200

537

3.90

65.20

6.6

3.7

—

(40767503) Oxygen content in Capillary blood by calculation

191

501

3.98

64.32

3.8

2.2

15.2

16.6

3.63

104

266

(21494815) CD4 cells/100 lymphocytes in Specimen

146

6.96

64.06

2.8

2.5

22.5

46.1

—

(3021901) Oxygen saturation in Capillary blood

180

454

4.13

63.95

4.1

2.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

162

379

4.44

63.51

1.5

1.3

252.0

240.7

u/ml

0.18

104

223

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

213

609

3.67

63.38

1.6

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

104

8.26

63.28

2.0

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1046

6348

1.94

63.22

1.8

1.5

18.8

20.3

nmol/l

2.95

946

5370

(3015235) Bicarbonate [Moles/volume] in Capillary blood

220

644

3.59

63.19

4.6

2.8

24.1

24.8

mmol/l

1.14

203

554

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

221

649

3.57

63.17

6.9

4.5

2.0

1.4

mg/l

10.39

201

588

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

154

348

4.59

63.06

1.1

—

(3021788) Differential panel - Synovial fluid

165

397

4.32

62.38

1.9

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

252

815

3.26

61.85

4.0

2.3

2.2

1.1

g/l

1.44

211

688

(3042733) HLA Ab [Presence] in Serum

11.45

60.48

4.7

4.8

—

(3023199) Leukocytes [#/volume] in Pleural fluid

142

313

4.69

59.94

1.6

1.4

7893.6

1944.3

e6/l

0.44

104

227

(3015377) Calcium [Moles/volume] in Serum or Plasma

1305

8631

1.84

59.52

5.0

3.0

2.3

2.4

mmol/l

11.25

1152

7401

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

295

1071

2.92

59.25

7.1

4.5

1.8

1.6

1.10

273

998

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

480

2225

2.35

58.49

3.2

2.2

33.2

37.8

u/l

0.69

414

1898

(3003434) Protein [Mass/volume] in Pleural fluid

151

357

4.38

58.38

1.5

1.4

30.8

32.0

g/l

0.48

127

322

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

203

596

3.56

57.99

1.5

1.3

—

(3037522) Nuclear Ab [Titer] in Serum

580

2920

2.19

57.93

1.4

1.3

515.3

506.2

titre

0.04

119

596

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

8.23

56.41

2.1

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

228

736

3.25

56.04

3.5

2.1

35.2

38.4

g/l

9.39

195

628

(3017704) Immunofixation for Urine

108

7.56

56.01

2.2

1.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

9.46

55.46

36.9

35.0

7.2

7.3

ug/l

0.03

(3000475) Leukocytes [#/volume] in Synovial fluid

189

546

3.61

55.30

1.9

1.6

40651.4

13613.5

e6/l

2.39

130

392

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

8.11

55.05

2.1

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

285

1060

2.85

54.65

7.4

4.5

0.9

0.76

267

988

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

165

439

3.90

54.41

4.8

3.5

60.5

56.8

2.20

165

439

(3007164) IgA [Mass/volume] in Serum or Plasma

787

4532

1.96

54.25

2.1

1.4

2.7

2.5

g/l

1.81

573

2634

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

140

6.50

54.18

1.6

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

107

202

5.44

54.01

3.4

2.8

59.9

54.5

1.15

123

(40760892) CBC W Ordered Manual Differential panel - Blood

886

5317

1.90

53.92

7.2

4.1

—

(3047181) Lactate [Moles/volume] in Blood

238

811

3.08

53.37

8.6

5.2

1.4

1.3

mmol/l

0.47

205

717

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1547

11014

1.75

53.13

2.5

2.0

92.3

94.3

pmol/l

0.99

934

5756

(3044941) Cell count panel - Synovial fluid

145

362

4.14

52.17

1.8

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

219

723

3.17

51.81

5.5

2.8

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

205

652

3.28

51.58

1.4

1.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1437

10115

1.73

50.64

3.0

2.1

75.3

77.5

nmol/l

2.18

1295

8930

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

118

6.83

50.51

1.8

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

213

703

3.17

50.40

3.8

2.1

0.1

0.0

g/l

0.20

199

636

(3028308) Erythrocytes [#/volume] in Pleural fluid

125

286

4.50

50.36

1.6

1.4

89361.3

64352.1

e6/l

0.31

169

(3007566) Smooth muscle Ab [Titer] in Serum

187

573

3.40

49.93

1.2

77.7

94.0

titre

0.27

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

120

6.72

49.72

1.8

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

200

646

3.23

49.04

3.8

2.2

0.0

g/l

0.00

187

592

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

202

657

3.21

48.96

3.8

2.1

0.0

g/l

0.23

188

593

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

133

6.29

48.45

2.8

2.2

583.3

689.7

e6/l

0.59

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

178

5.46

48.35

1.2

—

u/ml

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2346

19034

1.77

48.29

6.3

3.8

23.2

11.5

mm/h

100.09

2203

17447

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

278

1099

2.67

47.24

5.3

3.5

50.3

46.8

1.42

272

1088

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

172

5.47

46.93

2.0

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

172

5.47

46.93

2.0

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

172

5.47

46.93

2.0

1.4

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

9.19

46.92

2.9

2.6

35.1

27.5

2.18

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

7.84

46.37

1.9

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

7.84

46.37

1.9

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

477

2424

2.13

45.75

2.7

2.3

8.8

7.8

ug/l

0.35

418

2125

(3012441) Differential panel - Pleural fluid

115

266

4.44

45.70

1.5

1.4

—

(3006245) CD3-CD19+ cells/100 cells in Blood

8.66

45.62

2.9

3.1

12.8

12.6

0.02

(3045788) Cell count panel - Pleural fluid

110

249

4.53

44.92

1.7

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

187

5.14

44.76

1.3

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2948

25939

2.11

44.13

44.6

12.1

39.3

23.8

mg/l

79.88

2758

20261

(3042111) Morphology [Interpretation] in Bone marrow Narrative

147

419

3.62

43.83

2.6

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

106

238

4.57

43.72

3.6

2.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

127

328

3.98

43.62

1.3

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2041

16174

1.67

43.28

5.4

2.9

82.3

48.0

u/l

21.25

1906

14935

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

198

4.91

42.87

4.2

2.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

198

4.91

42.87

2.6

2.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

6.92

42.83

3.0

3.6

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

7.78

42.51

1.2

1.1

296.0

165.9

iu/ml

1.18

(3039000) Anion gap in Blood

178

585

3.16

42.35

9.7

5.8

11.7

11.3

mmol/l

0.89

160

517

(3018572) Chloride [Moles/volume] in Blood

178

586

3.15

42.23

9.7

5.8

104.1

105.3

mmol/l

1.96

160

518

(3035350) Ketones [Presence] in Urine by Test strip

1651

12456

1.64

42.02

5.1

3.4

0.0

estimate

0.50

382

2301

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

7.24

41.95

2.2

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

7.24

41.95

2.2

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

7.24

41.95

2.2

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

7.24

41.95

2.2

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

486

2564

2.05

41.95

3.8

3.9

31.0

15.9

ug/l

0.47

398

2107

(3025941) Bacteria identified in Stool by Culture

285

1208

2.49

41.83

1.4

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

126

334

3.88

41.74

1.7

0.8

0.9

g/l

0.10

272

(3027135) IgG subclass 1 [Mass/volume] in Serum

211

4.70

41.60

1.4

1.3

9.0

6.7

g/l

1.68

161

(3024471) HLA-A [Type]

8.53

41.23

1.0

—

(4062490)

210

4.68

40.89

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

211

4.65

40.66

1.4

1.3

2.6

3.0

g/l

0.82

159

(3024139) IgG subclass 3 [Mass/volume] in Serum

211

4.65

40.66

1.4

1.3

0.4

g/l

0.17

160

(3034770) Mitochondria Ab [Titer] in Serum

174

578

3.12

40.65

1.2

384.0

1311.7

titre

—

(3018405) Lactate [Moles/volume] in Arterial blood

227

877

2.70

40.26

5.7

3.6

1.5

1.4

mmol/l

0.28

222

870

(3015736) pH of Urine

1339

9659

1.64

40.23

4.6

3.2

—

6.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

409

2053

2.13

40.22

2.6

2.2

364.7

372.4

nmol/l

0.23

383

1861

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

114

6.16

40.04

2.3

2.9

37.6

38.5

0.10

(3023419) Bacteria identified in Sputum by Culture

116

299

3.98

39.96

2.5

—

(3024932) HLA-DR beta [Type]

8.37

39.84

1.1

1.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

152

471

3.33

39.83

1.7

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

1659

12645

1.62

39.64

5.1

3.5

0.0

estimate

0.80

362

2254

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

221

4.49

39.30

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

172

579

3.08

39.28

2.9

2.0

122.3

131.7

g/l

4.63

137

416

(3021601) Nitrite [Presence] in Urine by Test strip

1640

12497

1.61

38.99

6.8

4.6

0.0

estimate

0.50

379

2333

(3009508) Creatinine [Moles/volume] in Urine

1206

8527

1.65

38.89

4.4

3.1

6.6

7.8

mmol/l

18.34

1016

7131

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

203

4.63

38.78

1.4

1.2

—

(3042631) Mycobacterium sp identified in Specimen

117

313

3.84

38.26

2.7

2.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

123

5.79

38.16

1.5

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

123

5.79

38.16

1.5

1.7

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

136

404

3.47

38.08

1.2

—

77.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

8.68

37.89

1.9

1.7

1759.1

6847.4

u/ml

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1873

14808

1.60

37.58

3.4

2.7

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

165

5.01

37.55

1.1

1.3

328.0

164.8

titre

0.58

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

197

4.61

37.38

1.4

1.1

71.0

68.7

u/l

0.06

136

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

7.92

36.62

2.3

1.5

—

(40768806) Pleura Pathology biopsy report

107

280

3.91

36.10

1.4

1.6

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

105

273

3.94

35.75

2.0

1.5

74.1

59.6

3.53

161

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

7.12

34.75

3.7

2.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1177

8481

1.60

34.00

5.1

3.9

27.0

7.6

mg/mmol

9.26

849

5425

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

7.59

33.96

2.2

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

7.59

33.96

2.2

1.5

—

(3000060) B lymphocytes [#/volume] in Blood

8.85

33.68

3.2

3.0

955.4

244.8

e6/l

0.42

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

251

3.95

33.25

3.4

3.1

—

(3012516) Albumin [Mass/volume] in Urine

1126

8078

1.59

32.87

4.4

3.2

760.9

264.5

mg/l

2.21

820

5184

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

112

5.62

32.84

1.5

1.1

32.5

14.1

u/l

2.02

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

7.85

32.76

1.1

—

(3020891) Body temperature

231

997

2.41

32.45

7.5

4.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

7.72

32.30

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

118

5.42

32.11

1.5

1.1

118.6

81.3

u/l

1.15

(3027456) Digoxin [Moles/volume] in Serum or Plasma

153

542

2.91

31.91

3.2

3.1

0.8

nmol/l

0.01

113

414

(3036782) Glucose [Moles/volume] in Pleural fluid

258

3.80

31.22

1.3

6.5

mmol/l

0.02

239

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

111

329

3.45

31.21

2.9

2.6

32.0

968.9

u/ml

0.60

106

314

(3016650) Hepatitis A virus Ab [Presence] in Serum

113

339

3.41

31.18

1.1

1.0

—

(3051651) Icteric interference index of Serum or Plasma

129

5.12

31.07

5.5

2.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

7.05

30.52

2.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

244

3.85

30.49

1.2

1.1

—

(4035726)

378

2039

1.96

30.12

1.6

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

471

2735

1.84

29.93

2.3

1.7

1.5

3.70

393

2406

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

112

343

3.34

29.92

1.1

1.0

—

(3037121) Protein [Mass/volume] in Urine

207

882

2.44

29.89

4.2

3.4

0.5

0.2

g/l

3.97

119

353

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

122

399

3.14

29.27

1.3

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

185

757

2.53

29.13

6.5

3.7

3.9

mmol/l

0.24

172

707

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

251

3.70

28.52

1.2

1.3

990.9

335.6

u/l

0.65

238

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

8.12

27.74

1.6

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

6.64

27.65

2.7

2.0

881.0

10909.3

e6/l

0.49

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

267

3.55

27.48

2.0

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

145

4.55

27.09

1.2

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

260

3.57

27.08

2.0

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

260

3.57

27.08

2.0

1.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

196

4.00

27.04

1.1

1.3

17.6

15.0

u/l

0.17

182

(3005988) Vibrio sp identified in Specimen by Organism specific culture

261

3.56

26.93

2.0

1.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

7.78

26.79

2.4

2.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

5.56

26.30

1.3

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

200

3.92

26.30

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

7.16

26.28

2.5

1.9

5514.8

8477.7

e6/l

0.32

(3024522) Salmonella sp identified in Specimen by Organism specific culture

266

3.49

26.17

2.0

1.3

—

(3047189) Immunofixation for 24 hour Urine

103

5.21

25.97

2.9

1.9

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

263

3.49

25.90

2.0

1.3

—

(3028433) Virus identified in Specimen by Culture

6.73

25.49

1.4

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

110

368

3.06

25.42

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

111

4.93

24.83

1.8

1.4

—

(21494434) Karyotype in Bone marrow

218

3.69

24.77

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

369

2109

1.84

24.43

9.8

3.1

1.2

mmol/l

3.33

343

1802

(3010144) Erythrocytes [#/volume] in Synovial fluid

211

3.71

24.40

1.6

1.3

29383.7

125719.9

e6/l

1.21

146

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

143

564

2.60

24.30

2.2

2.0

11.9

10.7

mg/l

0.89

129

520

(40768446) Kidney Pathology biopsy report

5.78

24.13

2.2

1.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

157

651

2.48

24.04

1.7

1.6

0.1

7.6

iu/ml

0.84

127

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

11.44

24.02

1.2

1.8

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

799

5656

1.54

23.20

1.9

1.7

61679874.8

32468510.6

pmol/l

0.44

655

4623

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

319

3.10

23.10

1.2

1.1

1.6

1.5

g/l

1.83

286

(3022493) Free Hemoglobin [Mass/volume] in Plasma

5.29

22.95

6.6

4.2

54.0

75.9

mg/l

1.70

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

10.07

22.94

5.0

6.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

6.15

22.82

1.1

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

212

3.60

22.72

2.1

1.4

21.3

28.0

1.05

125

(3019550) Sodium [Moles/volume] in Serum or Plasma

2944

27059

1.71

22.72

47.4

15.0

138.8

139.7

mmol/l

57.26

2891

26320

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

203

965

2.17

22.65

1.8

1.9

37.7

39.3

u/l

0.53

179

845

(3033799) Differential panel - Peritoneal fluid

6.61

22.56

2.9

1.7

—

(3002385) Erythrocyte distribution width [Ratio]

2431

21411

1.49

22.55

47.3

15.6

14.5

13.6

102.89

2393

20900

(3009542) Hematocrit [Volume Fraction] of Blood

2613

23362

1.53

22.52

40.9

14.1

36.9

39.8

41.65

1687

16178

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

693

4795

1.56

22.16

3.9

2.9

2.5

2.4

mmol/l

7.03

587

4182

(3045142) Bone marrow Pathology biopsy report

271

3.23

22.01

1.5

1.2

—

(40768441) Liver Pathology biopsy report

144

4.15

21.96

2.0

1.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2944

27125

1.69

21.67

48.1

15.1

4.0

mmol/l

1.69

2884

26348

(3051611) Lipemic interference index of Serum or Plasma

245

3.32

21.44

5.3

2.7

—

(3052592) Norovirus Ag [Presence] in Stool

7.56

21.22

1.2

—

(3044927) Protein electrophoresis panel - Urine

247

3.29

21.17

1.3

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

8.06

20.89

2.8

1.6

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

6.19

20.64

3.2

2.3

—

(40761536) Microorganisms panel - Urine sediment

360

2147

1.76

20.55

6.5

3.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

149

649

2.36

20.49

2.7

1.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

187

896

2.15

20.45

3.1

372.5

4848.4

u/ml

0.84

155

775

(3013512) EKG study

1017

7730

1.45

20.35

5.8

3.9

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

10.06

20.27

1.0

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

812

5930

1.49

19.87

4.5

3.4

—

(3035880) pH of Pleural fluid

151

3.89

19.81

1.3

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

8.68

19.77

2.5

2.6

26.6

31.1

mg/l

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

233

3.27

19.67

1.2

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

158

3.78

19.38

3.1

1.9

—

(3003181) Sodium [Moles/volume] in Urine

109

422

2.64

19.27

1.7

1.3

61.8

64.9

mmol/l

0.29

342

(3040151) Glucose [Moles/volume] in Capillary blood

278

3.04

19.21

8.9

4.8

7.8

7.1

mmol/l

0.81

234

(3044007) Cell count panel - Peritoneal fluid

5.91

19.15

2.7

2.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

11.17

18.88

1.4

—

(3017732) Neutrophils [#/volume] in Blood

280

1593

1.83

18.69

4.1

2.9

4.3

4.1

e9/l

0.35

202

1203

(3002331) Protein [Mass/volume] in Peritoneal fluid

7.70

18.68

1.4

1.2

23.8

30.6

g/l

0.77

(3041096) Erythrocytes [Presence] in Urine by Automated

889

6680

1.45

18.59

5.1

3.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

16.07

18.51

1.4

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

104

403

2.63

18.37

8.3

2.9

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

5.62

18.19

1.3

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

264

3.00

17.75

1.2

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

175

3.47

17.41

1.2

1.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

180

3.43

17.38

1.7

1.4

1.6

1.2

promille

0.78

142

(3008037) Lactate [Moles/volume] in Venous blood

129

569

2.32

17.27

4.4

2.9

1.7

1.6

mmol/l

0.15

124

555

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

121

4.01

17.17

2.1

1.5

8.5

6.9

u/l

0.21

(40768797) Stomach Pathology biopsy report

505

3433

1.55

17.06

1.3

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

146

3.67

16.75

1.4

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

10.05

16.70

5.5

3.8

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

175

3.41

16.69

1.0

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

5.96

16.50

2.2

1.3

15.0

15.1

g/l

0.01

(3033705) Calcium.ionized [Moles/volume] in Venous blood

303

2.78

16.49

3.6

2.0

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

6.32

16.28

1.9

1.1

—

(3011288) Drugs identified in Urine by Screen method

111

474

2.39

16.02

5.9

2.5

—

(3002256) Pathology report gross observation

493

3385

1.53

15.85

1.3

—

(3019225) pH of Specimen

402

2635

1.60

15.84

9.5

3.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

237

1348

1.82

15.81

1.4

1.3

197.9

235.3

u/ml

0.48

216

1250

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

142

682

2.13

15.48

1.3

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

109

469

2.37

15.47

1.5

1.2

60.6

32.3

u/l

1.01

102

404

(3014765) Yersinia sp identified in Stool by Organism specific culture

143

689

2.12

15.46

1.3

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1193

9669

1.36

15.41

5.8

3.6

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

105

4.04

15.22

1.3

1.4

49.4

63.1

1.23

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

123

3.78

15.20

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

123

3.78

15.20

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

4.16

15.09

3.3

2.5

—

(3019977) pH of Arterial blood

133

3.65

15.07

2.3

2.8

7.4

0.19

(42529406) Shigella sp [Presence] in Stool by Culture

143

697

2.10

15.01

1.3

1.1

—

(40768443) Skin Pathology biopsy report

200

1098

1.87

14.94

1.3

1.2

—

(40757373) Influenza virus identified in Isolate

5.78

14.92

1.4

1.6

—

(3025549) Creatine [Moles/time] in 24 hour Urine

10.05

14.92

1.4

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

5.04

14.77

7.5

7.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

122

3.72

14.59

3.5

—

(3036525) Urea [Moles/time] in 24 hour Urine

27.28

14.26

3.2

3.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

141

698

2.06

14.22

1.4

254.9

287.2

ug/g

0.88

416

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

8.61

14.13

1.3

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

4.56

13.99

7.9

6.9

—

(3014271) Vancomycin [Susceptibility]

131

3.55

13.89

3.4

2.8

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

238

1408

1.74

13.89

4.0

2.6

0.3

e6/l

0.28

232

1381

(3029937) Albumin [Presence] in Urine by Test strip

873

6824

1.38

13.86

6.1

3.8

0.0

estimate

0.28

329

2239

(3036603) Volume of Urine

137

3.47

13.71

1.4

1.6

1799.9

1829.4

—

(44786800) Granulocytes/100 leukocytes in Body fluid

6.81

13.57

1.3

1.4

28.8

15.0

0.73

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

119

3.65

13.55

1.2

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

13.05

13.37

4.0

7.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

135

3.44

13.29

1.0

1.1

—

(40768804) Tissue Pathology biopsy report

1227

10161

1.33

13.17

2.3

2.1

—

(3016750) Collection duration of Urine

156

3.24

13.13

2.5

1.8

523.9

496.9

min

0.82

106

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

108

3.74

13.07

1.7

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

6.14

12.92

2.6

1.5

—

(3025315) Body weight

10.81

12.86

6.1

3.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

174

3.08

12.80

1.5

31.2

24.5

u/ml

0.28

(40761511) CBC panel - Blood by Automated count

2874

26968

1.45

12.72

37.4

12.1

—

(3011648) Oxygen content in Venous blood

207

2.88

12.69

2.8

3.6

9.9

11.0

1.25

207

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

337

2.44

12.45

1.5

1.2

4.0

3.3

u/ml

0.22

116

(40768795) Lymph node Pathology biopsy report

204

2.88

12.43

1.3

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

317

2.46

12.12

6.1

2.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

110

3.58

11.98

1.2

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

111

3.54

11.83

1.8

1.4

2.8

6.9

0.97

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

5.26

11.53

3.7

3.1

—

(3044889) 12 lead EKG panel

2058

18471

1.29

11.47

5.5

3.9

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

109

3.51

11.40

1.1

1.2

1.1

ratio

0.36

(3000012) Reticulocyte production index

144

3.15

11.38

1.3

1.4

—

(3003694) ABO and Rh group [Type] in Blood

873

7011

1.33

11.22

1.5

1.4

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

3.67

11.22

1.5

2.0

175.7

152.7

0.78

(44816559) Phosphatidylethanol [Mass/volume] in Blood

426

2.19

11.09

1.8

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

116

3.39

11.08

1.4

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

112

562

2.03

10.96

5.5

2.0

—

(3004451) EKG impression Narrative

122

3.31

10.94

1.5

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

109

542

2.04

10.93

1.2

8.1

8.3

u/ml

0.02

(3044290) Cell count panel - Cerebral spinal fluid

464

2.12

10.78

2.3

1.5

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

140

3.10

10.58

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

140

3.10

10.58

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

140

3.10

10.58

1.0

1.1

—

(3004775) Volume in Urine collected for unspecified duration

217

2.65

10.57

2.6

2.1

767.8

596.7

1.69

134

(3009871) Measles virus Ab [Titer] in Serum

4.49

10.48

1.7

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

113

579

1.98

10.44

1.2

37.9

52.5

u/ml

0.27

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2922

27698

1.42

10.39

45.1

15.1

98.1

79.9

umol/l

30.64

2922

27689

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

431

2.14

10.39

1.3

1.2

1.1

6.3

u/ml

0.61

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

142

3.05

10.34

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

103

513

2.04

10.30

1.9

1.4

4.0

3.8

mmol/l

0.87

482

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

100

493

2.06

10.28

3.3

3.1

421.2

589.7

u/ml

0.19

455

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

4.72

10.23

7.1

7.9

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

106

536

2.01

10.18

1.3

1.2

1.8

3.1

u/ml

1.09

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

303

2055

1.52

10.17

3.5

2.5

52.3

66.4

ml/min/173m2

6.89

149

827

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

7.81

10.14

6.9

2.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

122

649

1.91

10.12

2.9

2.3

201.2

106.6

ug/min

1.14

388

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

224

2.57

9.95

1.1

1.2

1.5

nmol/l

0.05

199

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2914

27649

1.40

9.94

21.5

9.4

27.1

26.4

u/l

0.99

2838

26486

(3045716) Anion gap in Serum or Plasma

135

3.06

9.92

2.3

2.4

9.7

9.5

mmol/l

0.09

105

(3014891) Appearance of Pleural fluid

5.45

9.92

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

253

1658

1.57

9.91

1.8

1.7

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

16.74

9.86

1.5

1.1

—

(21494755) Public health laboratory ask at order entry panel

101

1893

0.52

9.78

1.2

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

299

2.34

9.77

1.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

157

914

1.75

9.75

5.1

3.2

47.1

64.0

u/ml

0.72

152

872

(3042517) Benzodiazepines panel - Urine

8.15

9.73

4.1

1.9

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

142

2.98

9.72

1.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

142

2.98

9.72

1.0

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2597

24238

1.31

9.70

35.5

12.3

74.4

78.6

ml/min/173m2

12.78

2298

19778

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

4.36

9.32

2.2

2.3

—

(3048879) Bone marrow aspiration report

3.96

9.31

2.0

1.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

312

2.27

9.31

4.8

4.4

365.1

349.7

umol/l

0.44

269

(3015171) Extractable nuclear Ab [Units/volume] in Serum

141

807

1.78

9.29

1.3

1.2

0.4

0.6

u/ml

0.36

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

7.67

9.27

1.1

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

197

2.61

9.24

1.3

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

327

2.23

9.16

1.6

1.2

5.7

4.4

u/ml

0.37

145

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

3.99

9.04

1.4

1.3

34.3

23.0

0.65

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2093

19082

1.26

9.04

4.0

3.7

14.8

14.9

pmol/l

0.77

1875

17106

(3000492) Spirometry study

324

2284

1.46

8.99

1.7

1.4

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

24.06

8.90

1.2

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

6.69

8.89

1.6

2.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.61

8.82

1.5

1.2

—

(40761535) Cells panel - Urine sediment

311

2183

1.47

8.82

5.2

3.2

—

(3016879) Cocaine [Presence] in Urine

122

680

1.82

8.80

5.4

1.9

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2514

23465

1.28

8.71

4.9

4.4

2.0

2.1

mu/l

0.20

2293

21189

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

5.33

8.68

1.4

1.3

70.3

73.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

511

1.95

8.68

2.4

1.6

658.0

1065.3

e6/l

0.31

421

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

6.02

8.65

1.0

1.2

12.7

25.3

u/l

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

10.03

8.64

1.1

1.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

512

1.94

8.63

2.3

1.5

149.8

10.3

e6/l

1.19

401

(3008295) Osmolality of Serum or Plasma

253

2.36

8.60

1.2

1.4

281.4

279.1

mosm/kgh2o

0.21

184

(3000764) Benzodiazepines [Presence] in Urine

128

730

1.78

8.57

5.3

1.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

217

1422

1.56

8.53

2.7

2.4

—

(4198724)

3.52

8.51

2.4

1.7

—

(3017569) Oxygen content in Arterial blood

126

2.96

8.49

1.8

2.6

—

(3027008) Opiates [Presence] in Urine

128

734

1.77

8.41

5.2

1.9

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

262

2.31

8.40

4.8

3.6

48.2

35.7

u/ml

0.33

252

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

4.89

8.35

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

3.39

8.34

1.1

1.2

—

(3016038) Potassium [Moles/volume] in Urine

161

2.69

8.31

1.7

1.3

29.6

34.7

mmol/l

0.81

141

(3028300) Cannabinoids [Presence] in Urine

128

738

1.76

8.27

5.4

1.9

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.83

8.23

1.0

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

240

2.36

8.19

2.1

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

180

1140

1.61

8.18

1.4

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

3.70

8.17

1.1

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

4.37

8.14

2.1

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

7.88

7.99

1.3

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.53

7.96

2.8

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.53

7.96

2.8

2.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

117

666

1.78

7.91

4.9

3.8

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

121

2.91

7.85

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

3.24

7.79

1.3

1.5

1.4

2.7

0.64

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

312

2.14

7.67

1.2

1.1

—

(4281824)

192

2.47

7.65

1.3

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

5.62

7.54

2.1

2.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

5.62

7.54

1.0

—

(3002619) Bacteria identified in Specimen by Culture

4.24

7.47

1.5

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

3.75

7.35

1.2

1.1

—

(3027944) Amphetamines [Presence] in Urine

122

720

1.72

7.30

5.2

1.9

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

4.15

7.27

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

3.50

7.26

1.6

1.2

13.3

34.1

3.06

(3036670) Protein [Mass/volume] in Synovial fluid

3.50

7.26

1.5

1.1

43.1

38.6

g/l

0.77

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

101

568

1.80

7.14

1.3

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

3.56

7.14

1.2

—

(3000330) Specific gravity of Urine by Test strip

199

1335

1.52

7.07

4.4

3.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

5.67

7.06

4.2

1.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

5.20

6.96

2.1

2.3

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

4.59

6.92

1.3

1.2

38.7

29.7

u/l

—

(3035320) C reactive protein [Mass/volume] in Body fluid

183

2.42

6.92

4.4

2.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

138

2.63

6.71

1.7

2.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

186

2.38

6.70

1.1

1.0

291.0

283.2

mg/l

0.28

166

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

144

2.59

6.69

1.1

1.4

—

57.5

—

(3049717) Cytology report of Urine Cyto stain

177

1173

1.54

6.67

2.6

2.7

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

5.73

6.58

1.3

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

4.16

6.54

1.2

1.8

2.3

mmol/l

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

512

1.80

6.46

1.8

1.6

1.1

0.8

nmol/l

2.01

429

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

165

2.44

6.43

1.2

1.1

6.3

2.3

u/ml

—

(3007463) Buprenorphine [Presence] in Urine

14.32

6.39

13.1

4.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

135

851

1.61

6.33

1.7

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

3.17

6.28

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

3.85

6.25

1.3

1.2

1.3

1.6

mmol/l

0.62

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

635

5237

1.26

6.20

1.4

1.3

3.6

1.7

u/ml

1.17

147

1319

(3029075) Extractable nuclear Ab panel - Serum

3.52

6.15

1.1

1.0

—

(3007461) Platelets [#/volume] in Blood

2999

28952

1.33

6.12

57.5

18.8

240.5

243.4

e9/l

1.20

2945

28087

(3010813) Leukocytes [#/volume] in Blood

3001

28976

1.33

6.11

57.5

18.8

7.5

6.8

e9/l

22.04

2936

28021

(1761868) Lipid panel - Serum or Plasma

715

8450

0.80

6.09

3.3

2.9

—

(3024731) MCV [Entitic volume]

2999

28964

1.33

6.01

57.3

18.8

91.5

91.1

4.02

2961

28465

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

5.23

6.00

1.6

1.4

—

(3035941) MCH [Entitic mass]

2999

28965

1.33

6.00

57.2

18.7

30.2

30.4

5.91

2961

28466

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.25

5.99

1.2

1.1

78.6

84.0

0.39

(3026361) Erythrocytes [#/volume] in Blood

2999

28968

1.33

5.97

57.5

18.8

4.2

4.5

e12/l

174.36

2935

28011

(3006653) Thiamine [Moles/volume] in Blood

112

2.69

5.91

1.4

1.2

142.5

140.4

nmol/l

0.07

112

(3000963) Hemoglobin [Mass/volume] in Blood

2999

28975

1.32

5.90

58.0

18.9

124.1

136.5

g/l

249.40

2958

28485

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.90

5.88

1.2

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

580

1.71

5.88

2.0

2.2

2678.7

3949.3

u/l

0.34

221

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.40

5.86

1.4

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.01

5.74

1.2

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.35

5.71

1.3

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

175

2.30

5.69

1.3

1.4

14.8

13.1

umol/l

0.63

161

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1264

0.56

5.68

1.3

1.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

3.71

5.64

1.2

1.1

93.9

80.9

—

(3004616) Nuclear Ab [Presence] in Serum

261

2.05

5.63

1.4

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

959

0.50

5.54

1.6

1.7

—

(3022145) Colonoscopy Study observation

357

2774

1.32

5.52

1.5

1.3

—

(4306422)

312

1.94

5.49

1.1

1.2

—

(4010399)

246

1808

1.39

5.46

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.78

5.46

1.2

3.4

53.3

167.2

umol/l

2.89

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

125

1897

0.65

5.46

1.7

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

414

1.81

5.41

1.2

51.8

40.5

u/ml

0.20

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

573

1.68

5.35

1.1

1.3

187.6

240.2

miu/ml

0.51

244

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.35

5.29

1.0

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

247

2.04

5.29

1.3

1.2

38.1

45.2

u/ml

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

11.28

5.29

5.7

5.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.63

5.25

1.1

1.0

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

3.06

5.21

1.3

1.1

105.4

95.9

0.49

(3019150) Specific gravity of Urine by Refractometry

664

5609

1.23

5.15

5.8

3.8

1.0

kg/l

0.77

110

849

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.95

5.14

1.5

1.1

—

(3023410) Appearance of Cerebral spinal fluid

239

2.02

4.99

2.8

1.7

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.97

4.98

1.2

62.6

610.9

ug/l

0.72

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.00

4.82

1.4

1.3

81.4

78.0

0.20

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

469

3843

1.26

4.79

1.5

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

9.02

4.78

1.2

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

9.02

4.78

1.2

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.60

4.78

1.1

1.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

5.01

4.77

10.6

9.1

0.4

umol/l

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

157

2.24

4.75

1.6

1.3

0.9

1.1

u/ml

0.09

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

3.42

4.74

1.1

1.0

71.8

85.3

—

(3024263) Appearance of Synovial fluid

126

2.39

4.72

1.7

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

182

1304

1.42

4.72

3.6

3.4

4.3

4.6

pmol/l

1.32

162

1134

(3039443) Prostate specific Ag panel - Serum or Plasma

601

0.43

4.72

1.5

1.7

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.34

4.60

2.4

1.3

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

8.20

4.56

1.1

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

10.02

4.52

1.1

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.42

4.46

1.0

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

4.01

4.43

1.7

1.3

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

3.21

4.33

6.3

2.9

85.7

142.8

u/l

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.89

4.33

1.2

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

317

1.81

4.32

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

119

2.36

4.32

4.4

5.9

30.4

59.7

u/ml

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.96

4.28

1.2

1.1

—

(40758292) HTLV I+II Ab panel - Serum

3.88

4.25

1.5

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.94

4.16

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.87

4.06

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

465

3880

1.23

4.02

1.3

1.2

44.9

33.9

iu/ml

0.83

151

1166

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

10.02

4.01

7.0

4.9

447.3

363.0

umol/l

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

143

2.18

3.98

1.7

1.2

—

(3020491) Glucose [Moles/volume] in Blood

191

2.00

3.92

3.5

1.8

8.5

6.6

mmol/l

2.62

124

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

144

2.16

3.92

1.7

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.18

3.88

1.9

1.6

51.9

39.5

umol/l

—

(4268621)

227

1.91

3.87

2.9

2.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

6.01

3.81

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.84

3.79

1.2

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

140

2.15

3.76

2.6

1.7

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

12.02

3.76

1.0

1.4

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

108

2.32

3.75

1.9

1.4

41.2

69.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.74

3.75

1.3

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.51

3.71

1.1

1530.1

1625.9

miu/ml

0.15

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.01

3.68

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2499

23974

1.16

3.64

8.0

5.8

42.9

39.9

mmol/mol

28.27

2313

21980

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.68

3.63

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

10.01

3.49

11.3

5.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

583

1.52

3.48

1.1

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

624

1.50

3.47

1.7

1.5

11.9

8.2

u/l

1.91

498

(3027923) C peptide [Moles/volume] in Serum or Plasma

140

2.08

3.37

1.2

1.4

0.9

1.1

nmol/l

0.52

108

(3020393) Adenovirus Ag [Presence] in Stool

3.71

3.35

1.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

8.58

3.26

1.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.79

3.25

4.7

3.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.03

3.25

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

324

1.68

3.24

1.7

30.5

25.4

ug/l

0.21

319

(36660697) Celiac disease serology panel - Serum

239

1898

1.28

3.22

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

107

751

1.44

3.21

1.9

1.7

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

6.37

3.18

1.4

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

391

1.60

3.08

1.0

1.1

26.1

91.6

iu/ml

1.00

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

431

3668

1.20

3.07

1.3

1.2

13.2

12.1

u/ml

0.09

127

1416

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

376

1.61

3.06

1.6

—

(40765096) Chromosome analysis panel by Banding

2.38

3.05

1.4

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

5.01

3.05

3.0

2.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.46

3.04

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.59

3.04

1.2

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

10.01

2.98

6.0

3.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

2.41

2.96

1.4

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

295

1.67

2.93

1.7

1.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.10

2.88

1.1

1.2

—

(4015189)

2.51

2.87

2.5

1.9

—

(3003338) MCHC [Mass/volume]

2276

21829

1.13

2.85

50.3

16.8

329.3

333.0

g/l

52.62

2248

21631

(3045414) Leukocytes [Presence] in Urine

147

1114

1.33

2.83

2.1

1.9

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

4.45

2.79

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.23

2.77

1.1

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.23

2.77

1.1

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.23

2.77

1.1

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

8.34

2.75

1.2

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

5.01

2.72

3.6

2.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.37

2.72

3.0

1.5

—

(3025130) Human papilloma virus identified in Specimen

189

1.81

2.70

2.1

1.8

—

(3010937) Rubella virus Ab [Presence] in Serum

6.01

2.70

1.0

1.2

—

(44806071)

4.22

2.67

1.0

1.1

—

(3034426) Prothrombin time (PT)

2.34

2.65

1.7

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

169

1.84

2.62

1.3

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

141

1.92

2.60

17.9

12.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

307

1.60

2.55

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

5.46

2.54

9.5

3.8

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

6.26

2.37

7.0

5.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

6.26

2.37

5.4

4.8

—

(3034988) Calcium [Moles/volume] in Capillary blood

2.42

2.36

5.6

2.1

1.2

mmol/l

0.03

(3013945) Hepatitis B virus e Ab [Presence] in Serum

4.62

2.27

1.2

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

2.28

2.24

2.3

1.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

5.56

2.21

2.4

1.0

—

(3022621) pH of Urine by Test strip

204

1671

1.24

2.19

3.7

2.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

489

0.59

2.17

1.9

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

329

1.53

2.16

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

212

1.66

2.13

1.7

2.5

15.5

6.5

umol/l

0.62

145

(3048689) Calprotectin [Mass/mass] in Stool

324

2788

1.18

2.09

2.3

191.6

136.7

ug/g

1.19

261

2174

(3020356) Listeria sp identified in Specimen by Organism specific culture

5.01

2.07

1.2

1.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

191

1.68

2.06

1.3

1.4

13.6

11.5

mmol/l

0.68

(3011985) Renin [Units/volume] in Plasma

301

1.54

2.05

1.5

1.3

59.1

74.3

mu/l

0.36

264

(4027681)

125

1.85

2.02

1.2

—

(3045424) Erythrocytes [Presence] in Urine

412

1.44

1.94

1.5

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.57

1.92

2.9

1.6

206.7

160.9

ng/l

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

592

1.36

1.90

1.3

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

308

1.50

1.87

1.2

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

151

1.73

1.86

2.2

2.1

115.1

158.7

ug/min

—

(3030313) Adrenal Ab [Titer] in Serum

3.53

1.83

1.2

1.1

—

(3019174) dRVVT (LA screen)

3.53

1.83

1.0

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

4.17

1.82

1.2

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

327

1.47

1.81

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.92

1.80

1.1

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.76

1.79

1.0

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.76

1.79

1.8

1.1

—

186.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

116

1.82

1.78

2.0

2.3

62.9

53.1

umol/l

0.62

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

395

1.42

1.77

1.7

1.6

—

(4094501)

735

0.70

1.77

1.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

240

1.55

1.76

1.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

1.90

1.75

1.2

1.1

80.8

162.5

ng/l

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.50

1.74

1.4

2.3

14.2

19.2

umol/l

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

3.85

1.71

1.0

1.1

0.0

0.8

u/ml

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.30

1.70

1.2

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

171

1.64

1.70

1.1

148.0

43.1

mg/l

0.71

144

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

133

1.73

1.69

1.5

1.6

1.9

3.3

u/field

0.44

(3024869) Neuronal Ab [Presence] in Serum

2.39

1.67

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.19

1.67

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

277

1.49

1.64

1.1

1.3

245.9

276.7

pmol/l

0.24

212

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.58

1.61

1.0

1.1

—

(3006270) Folate [Moles/volume] in Blood

222

1.54

1.59

1.3

1.2

311.9

347.1

nmol/l

0.47

189

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.95

1.59

1.4

1.2

117.2

130.8

nmol/l

—

(3002523) Influenza virus A Ag [Presence] in Specimen

329

1.43

1.58

1.1

—

(3018133) Calcium [Moles/volume] in Urine

2.20

1.57

2.5

2.6

mmol/l

0.06

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

107

852

1.26

1.55

1.7

1.8

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.28

1.53

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

284

0.56

1.53

1.1

7.9

4.1

u/ml

—

126

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.34

1.52

1.8

4.7

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.86

1.50

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

218

1.52

1.48

1.1

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

116

1.73

1.48

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

242

0.54

1.46

1.0

0.1

0.3

u/ml

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

576

1.31

1.45

6.3

2.9

41.6

28.1

mg/l

1.66

362

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

641

6930

0.91

1.44

2.8

3.2

0.8

ug/l

0.07

438

4767

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

901

9588

0.92

1.43

4.1

4.5

23.1

21.9

1.16

409

4916

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.73

1.43

1.0

1.1

7.8

11.5

u/l

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

103

1.75

1.40

2.7

1.7

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.25

1.40

1.7

1.6

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

136

0.44

1.40

1.3

1.4

6.0

mmol/l

—

130

(3010726) Horse dander IgE Ab [Units/volume] in Serum

362

0.63

1.39

1.0

1.1

3.7

2.6

u/ml

—

101

(3021387) Prolactin [Units/volume] in Serum or Plasma

660

1.28

1.39

1.6

1.7

303.6

308.9

mu/l

0.07

605

(3047007) Chlamydophila sp Ab [Presence] in Serum

306

1.41

1.36

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

1.34

0.0

2.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

729

6804

1.09

1.30

1.9

1.6

1.5

1.3

mmol/l

3.52

615

5653

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.50

1.30

1.2

1.0

—

(40768800) Prostate Pathology biopsy report

802

0.77

1.26

1.0

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

736

1.24

1.22

1.6

1.5

23.3

26.3

iu/l

0.45

604

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

221

1.45

1.21

1.7

2.0

0.8

1.8

u/field

1.76

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

312

0.64

1.20

1.2

1.3

7.1

7.4

mmol/l

0.27

226

(3005011) Chlamydia sp Ab [Titer] in Serum

2.11

1.18

1.5

1.7

—

(40768793) Breast Pathology biopsy report

428

1.31

1.17

1.4

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

158

1.52

1.14

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

379

0.68

1.14

1.3

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

343

0.67

1.13

1.3

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

258

0.62

1.12

1.1

1.4

5.6

u/ml

—

118

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

119

1.60

1.11

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

595

1.25

1.07

2.7

2.1

—

(4146454)

296

1.36

1.06

2.4

2.6

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.12

1.05

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

357

1.32

1.05

1.1

1.3

—

(3001729) Color of Synovial fluid

2.27

1.03

4.2

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

276

0.65

1.03

1.3

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

380

0.71

1.00

1.0

1.1

1.0

1.4

u/ml

0.19

192

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

344

0.70

0.99

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

344

0.70

0.99

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

343

0.70

0.98

1.3

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

284

0.67

0.97

1.3

1.5

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

1.74

0.96

3.0

4.2

7.9

8.1

mg/l

—

(44813793)

157

1.47

0.96

1.0

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

123

1424

0.86

0.92

1.2

104.7

147.9

iu/ml

0.55

506

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.14

0.91

1.3

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.14

0.91

2.2

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.63

0.90

2.2

2.4

—

(44806420)

1.63

0.90

1.7

2.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

618

1.22

0.90

1.1

9.5

6.9

u/ml

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

124

1070

1.16

0.90

1.8

1.9

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.07

0.89

1.0

1.2

—

(3022689) Creatine [Moles/volume] in Urine

1.69

0.88

1.6

1.4

—

(3000285) Sodium [Moles/volume] in Blood

1.91

0.88

1.1

—

(3005033) Fetal Nuchal fold Thickness US

275

0.69

0.85

1.3

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.78

0.84

2.1

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

327

1.29

0.83

2.5

1.9

26.7

20.8

mg/l

0.38

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

285

1.30

0.80

1.6

1.7

—

(3010838) Calcium [Moles/time] in 24 hour Urine

115

1.48

0.76

1.4

1.8

—

9.8

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.77

0.76

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.70

0.75

1.6

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

660

1.19

0.75

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

437

0.78

0.75

1.1

3.5

2.7

u/ml

0.09

210

(1002224) Polysomnography panel

883

0.85

0.73

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

107

1220

0.87

0.70

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.53

0.69

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

240

1.29

0.67

3.8

3.2

49.3

23.4

mg/l

0.70

188

(4133840)

1.61

0.65

1.6

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.50

0.63

1.9

1.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2552

25206

1.05

0.62

5.3

4.6

6.3

6.0

mmol/l

16.23

2283

22687

(3003888) Timothy IgE Ab [Units/volume] in Serum

391

0.79

0.62

1.0

1.1

4.5

6.5

u/ml

0.40

227

(3028717) Thiamine [Mass/volume] in Blood

1.67

0.61

1.0

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2489

25199

0.95

0.60

4.9

4.4

1.3

1.4

mmol/l

18.47

2275

22969

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.54

0.59

1.3

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

318

1.23

0.58

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.51

0.56

1.0

1.3

14.3

8.5

ug/l

1.05

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

116

1.38

0.54

1.0

1.1

—

(3008898) HLA-B27 [Presence]

728

0.86

0.53

1.0

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

286

1.23

0.52

1.1

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

347

3277

1.07

0.52

5.1

4.5

32.0

32.6

0.48

269

2125

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.43

0.52

1.7

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

245

2617

0.93

0.49

1.6

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

1.45

0.48

1.0

1.3

0.4

0.3

g/l

1.58

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.49

0.47

2.1

1.6

0.3

0.1

nmol/l

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

814

0.88

0.47

1.7

10.8

3.9

mg/l

1.11

570

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.43

0.46

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.59

0.45

1.2

2.0

—

(3051101) Glucose [Moles/volume] in Cord blood

1.37

0.44

1.1

6.9

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.56

0.42

1.4

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

285

2700

1.06

0.42

1.5

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

277

1.19

0.41

1.1

1.3

—

nmol/l

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.47

0.40

1.4

1.0

—

(4211845)

133

1.28

0.38

1.9

3.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.39

0.38

1.6

—

(3020650) Glucose [Presence] in Urine

1.34

0.38

1.9

1.6

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.34

0.38

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

1.35

0.37

2.5

2.8

28.3

30.3

umol/l

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2520

25415

0.97

0.37

5.0

4.5

4.3

4.5

mmol/l

27.64

2328

23321

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

146

0.75

0.36

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.32

0.33

2.7

1.9

33.6

111.6

ug/l

0.42

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

247

1.18

0.32

1.4

1.5

0.2

0.3

nmol/l

1.95

205

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

209

0.81

0.32

1.3

1.5

57.8

66.1

pmol/l

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

132

0.76

0.32

1.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

332

1.15

0.32

1.1

—

9.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

167

1580

1.06

0.29

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

119

1116

1.07

0.28

1.2

1.1

113.3

169.5

titre

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.27

0.27

1.1

1.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2581

25975

0.97

0.27

5.4

5.0

2.4

2.7

mmol/l

31.96

2348

23691

(3015183) Erythrocyte sedimentation rate

118

0.76

0.27

1.3

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

170

1614

1.06

0.27

2.3

2.4

35.1

23.1

au/ml

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

123

1.22

0.25

1.1

1.9

1.1

u/l

—

(4024509)

236

1.15

0.24

2.5

1.5

—

(3006462) Nitrate [Presence] in Urine

124

1.21

0.24

2.0

3.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

547

0.91

0.23

1.9

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

143

1.19

0.23

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

143

1.19

0.23

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.0

—

3.7

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

241

2328

1.04

0.21

2.5

2.1

10.4

12.7

nmol/l

4.50

202

2035

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

10.6

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

249

1.13

0.20

1.3

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.20

0.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.18

0.16

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

1.18

0.16

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.18

0.16

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.18

0.16

1.1

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

191

1962

0.97

0.13

1.3

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

169

0.89

0.12

3.0

1.6

3.3

3.7

ug/l

—

150

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

555

0.95

0.10

1.5

1.8

7.3

4.7

iu/l

0.42

182

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

216

0.93

0.08

5.5

4.8

15.2

54.9

u/ml

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.78

0.08

1.2

1.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

205

1.07

0.07

1.7

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

215

1.07

0.07

1.2

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.07

0.07

1.3

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

423

1.04

0.06

1.5

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

138

1.09

0.06

6.8

6.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

103

0.87

0.06

1.0

1.1

—

(4034850)

841

0.97

0.06

15.0

9.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

196

1933

1.01

0.06

1.9

2.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

339

3403

1.00

0.01

14.5

6.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2437

24355

1.00

0.01

4.5

4.0

1.4

1.3

mmol/l

12.75

2214

22025

(3032773) Endomysium IgG Ab [Titer] in Serum

217

0.97

0.01

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

792

1.01

0.01

2.2

1.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

213

2121

1.00

0.01

2.0

2.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

141

0.99

0.00

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1186

11864

1.00

0.00

5.1

5.3

8.0

3.3

ug/l

0.51

1040

10606

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

113

0.97

0.00

1.2

1.3

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3022670) pH of Venous cord blood

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

0.0

2.0

—

36.7

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.0

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

310

1.00

0.00

1.1

1.0

6.4

2.0

u/ml

0.53

122

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.2

—

(3044336) Cobalt [Moles/volume] in Urine

0.00

0.0

2.0

—

16.4

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

2.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

1.02

0.00

1.0

1.1

—

3.6

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.0

1.0

—

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

0.00

0.0

2.2

—

28.5

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_STREPTO_SEPSIS and mortality.

Females

Parameter	HR [95% CI]	p-value
AB1_STREPTO_SEPSIS	2.884 [2.5, 3.33]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.19

During the follow-up period (1.1.1998 — 31.12.2019), 2934 out of 9755 females with AB1_STREPTO_SEPSIS died.

Males

Parameter	HR [95% CI]	p-value
AB1_STREPTO_SEPSIS	3.242 [2.81, 3.74]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 4143 out of 12444 males with AB1_STREPTO_SEPSIS died.

Mortality risk

Mortality risk for people of age

years, who have AB1_STREPTO_SEPSIS.

N-year risk	Females	Males
1	0.266%	0.621%
5	1.546%	3.367%
10	3.906%	8.524%
15	7.522%	15.631%
20	13.365%	25.987%

Relationships between endpoints

↥

Index endpoint: AB1_STREPTO_SEPSIS – Streptococcal septicaemia

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Streptococcal septicaemia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints